This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| covid | ORG | 622 |
| covid 19 | ORG | 285 |
| infection | DISEASE | 273 |
| sars | DISEASE | 266 |
| stroke | DISEASE | 185 |
| sars cov 2 | ORG | 144 |
| coronavirus | TAXON | 140 |
| gbs | ORG | 103 |
| csf | ORG | 101 |
| virus | TAXON | 92 |
| cov | CHEMICAL | 86 |
| viral | TAXON | 76 |
| ios | ORG | 74 |
| pd | ORG | 70 |
| ms | ORG | 69 |
| guillain | GPE | 68 |
| china | GPE | 65 |
| cvd | ORG | 64 |
| coronavirus disease | DISEASE | 64 |
| wuhan | GPE | 52 |
| guillain barré | ORG | 52 |
| igg | ORG | 51 |
| depression | DISEASE | 45 |
| pneumonia | DISEASE | 44 |
| individuals | TAXON | 44 |
| ad | ORG | 41 |
| encephalitis | DISEASE | 38 |
| dmt | ORG | 37 |
| multiple sclerosis | DISEASE | 33 |
| coronavirus | TAXON | 33 |
| infections | DISEASE | 32 |
| anxiety | DISEASE | 31 |
| sars cov | ORG | 31 |
| ci | ORG | 30 |
| hemorrhagic | DISEASE | 30 |
| neurological diseases | DISEASE | 29 |
| ischemic stroke | DISEASE | 29 |
| death | DISEASE | 29 |
| cancer | DISEASE | 29 |
| nmd | ORG | 29 |
| mt | ORG | 29 |
| stroke | PERSON | 28 |
| respiratory failure | DISEASE | 26 |
| neurological symptoms | DISEASE | 26 |
| acute stroke | DISEASE | 26 |
| pa | ORG | 26 |
| ich | ORG | 26 |
| encephalopathy | DISEASE | 25 |
| dementia | DISEASE | 25 |
| hgg | ORG | 25 |
| neurological | ORG | 24 |
| seizures | DISEASE | 23 |
| burgdorferi | TAXON | 23 |
| anosmia | DISEASE | 23 |
| inflammation | DISEASE | 22 |
| neurodegeneration | DISEASE | 21 |
| sea | ORG | 21 |
| pms | ORG | 20 |
| fever | DISEASE | 19 |
| mri | ORG | 19 |
| viruses | TAXON | 18 |
| strokes | DISEASE | 18 |
| human | TAXON | 18 |
| hypertension | DISEASE | 17 |
| mers | GPE | 17 |
| cas | ORG | 17 |
| italy | GPE | 16 |
| cognitive impairment | DISEASE | 15 |
| parkinson s disease | DISEASE | 15 |
| viral infection | DISEASE | 14 |
| neurological complications | DISEASE | 14 |
| critically ill | DISEASE | 14 |
| upsit | ORG | 14 |
| pres | PERSON | 13 |
| csdh | ORG | 13 |
| ivt | ORG | 13 |
| met | DISEASE | 13 |
| cerebrovascular disease | DISEASE | 13 |
| angiotensin | CHEMICAL | 13 |
| headache | DISEASE | 13 |
| neurological disease | DISEASE | 13 |
| neurological disorders | DISEASE | 13 |
| iqr | ORG | 12 |
| cns | ORG | 12 |
| coronavirus disease | DISEASE | 12 |
| flair | ORG | 12 |
| deaths | DISEASE | 12 |
| mci | ORG | 12 |
| oi | ORG | 12 |
| acute ischemic stroke | DISEASE | 12 |
| man | TAXON | 12 |
| sepsis | DISEASE | 11 |
| bias | CHEMICAL | 11 |
| mers cov | ORG | 11 |
| lyme disease | DISEASE | 11 |
| karnofsky | PERSON | 11 |
| csc | ORG | 11 |
| middle east | LOC | 10 |
| tbi | ORG | 10 |
| comorbidity | DISEASE | 10 |
| neurological comorbidities | DISEASE | 10 |
| steroid | CHEMICAL | 10 |
| neuromuscular disease | DISEASE | 10 |
| sah | ORG | 9 |
| aidp | ORG | 9 |
| ards | GPE | 9 |
| borrelia burgdorferi | TAXON | 9 |
| conflicts | ORG | 9 |
| coronavirus disease | DISEASE | 9 |
| lyme | GPE | 9 |
| mis | ORG | 9 |
| ms disease | DISEASE | 9 |
| sa | ORG | 9 |
| pcr | ORG | 9 |
| sirs | ORG | 9 |
| hyposmia | DISEASE | 9 |
| polyneuritis | DISEASE | 9 |
| usa | GPE | 9 |
| meningoencephalitis | DISEASE | 9 |
| infectious | DISEASE | 9 |
| ncov | ORG | 9 |
| humans | TAXON | 9 |
| diabetes | DISEASE | 9 |
| bacterial | TAXON | 9 |
| vds | ORG | 9 |
| epidural abscess | DISEASE | 8 |
| asdh | ORG | 8 |
| canada | GPE | 8 |
| covid 19 | PERSON | 8 |
| emg | ORG | 8 |
| ifn | ORG | 8 |
| pns | ORG | 8 |
| rt pcr | ORG | 8 |
| ecmo | ORG | 8 |
| glioma | GPE | 8 |
| psychiatric symptomatology | DISEASE | 8 |
| seizure | DISEASE | 8 |
| respiratory syndrome | DISEASE | 8 |
| glucose | CHEMICAL | 8 |
| traumatic | DISEASE | 8 |
| oxygen | CHEMICAL | 8 |
| myelitis | DISEASE | 8 |
| virus | TAXON | 7 |
| alzheimer s disease | DISEASE | 7 |
| borrelia | ORG | 7 |
| ift | ORG | 7 |
| individuals | TAXON | 7 |
| lvo | ORG | 7 |
| meningitis encephalitis | DISEASE | 7 |
| rhabdomyolysis | ORG | 7 |
| uk | GPE | 7 |
| pbs | ORG | 7 |
| acute cerebrovascular disease | DISEASE | 7 |
| movement disorders | DISEASE | 7 |
| acute respiratory syndrome | DISEASE | 7 |
| viral infections | DISEASE | 7 |
| reperfusion | CHEMICAL | 7 |
| org licen | ORG | 7 |
| peripheral nervous system | DISEASE | 7 |
| iveco | ORG | 7 |
| dyspnea | DISEASE | 7 |
| coagulopathy | DISEASE | 7 |
| acute hemorrhagic necrotizing encephalopathy | DISEASE | 6 |
| demyelinating disease | DISEASE | 6 |
| delirium | DISEASE | 6 |
| cough | DISEASE | 6 |
| cerebrovascular diseases | DISEASE | 6 |
| bleeding | DISEASE | 6 |
| atrial fibrillation | DISEASE | 6 |
| città | ORG | 6 |
| sars cov 1 | ORG | 6 |
| results | ORG | 6 |
| igm | ORG | 6 |
| iga | ORG | 6 |
| amsterdam | GPE | 6 |
| hemiparesis | DISEASE | 6 |
| dizziness | DISEASE | 6 |
| ischaemic stroke | DISEASE | 6 |
| honoraria | GPE | 6 |
| neuropsychiatric symptoms | DISEASE | 6 |
| vessel stroke | DISEASE | 6 |
| intracerebral hemorrhage | DISEASE | 6 |
| tumor | DISEASE | 6 |
| thrombocytopenia | GPE | 6 |
| subdural haematoma | DISEASE | 6 |
| status epilepticus | DISEASE | 6 |
| thrombotic | DISEASE | 6 |
| neuromuscular diseases | DISEASE | 6 |
| neurological signs | DISEASE | 6 |
| neurological deficits | DISEASE | 6 |
| mice | TAXON | 6 |
| lymphopenia | DISEASE | 6 |
| hiv | TAXON | 5 |
| papa giovanni xxiii | PERSON | 5 |
| outcome | ORG | 5 |
| north america | LOC | 5 |
| neurological complications | DISEASE | 5 |
| mrc | ORG | 5 |
| lombardy | GPE | 5 |
| toast | DISEASE | 5 |
| infection | DISEASE | 5 |
| il | GPE | 5 |
| edss | CHEMICAL | 5 |
| guillain barre | ORG | 5 |
| gi | ORG | 5 |
| gcs | ORG | 5 |
| europe | LOC | 5 |
| eeg | ORG | 5 |
| depression | DISEASE | 5 |
| creative commons | ORG | 5 |
| copd | ORG | 5 |
| adc | ORG | 5 |
| acute necrotizing myelitis | DISEASE | 5 |
| wmhv | ORG | 5 |
| hematoma | DISEASE | 5 |
| agitation | DISEASE | 5 |
| methylprednisolone | CHEMICAL | 5 |
| animal | TAXON | 5 |
| teriflunomide | CHEMICAL | 5 |
| spondylodiscitis | DISEASE | 5 |
| obesity | DISEASE | 5 |
| neuronal death | DISEASE | 5 |
| neurological complication | DISEASE | 5 |
| neurologic complications | DISEASE | 5 |
| neuroinvasive | TAXON | 5 |
| mice transgenic | TAXON | 5 |
| the national health commission | ORG | 5 |
| lupus | DISEASE | 5 |
| encephalopathy syndrome | DISEASE | 5 |
| hypertensive | DISEASE | 5 |
| cyclophosphamide | CHEMICAL | 5 |
| demyelinating | DISEASE | 5 |
| autoimmune encephalitis | DISEASE | 5 |
| endotheliitis | DISEASE | 5 |
| ganglioside | CHEMICAL | 5 |
| hyperintensities | DISEASE | 5 |
| nyc | ORG | 4 |
| time | ORG | 4 |
| pneumonia | DISEASE | 4 |
| rct | ORG | 4 |
| sars cov 2 | ORG | 4 |
| sars cov 2 rt pcr | ORG | 4 |
| sars coronavirus | DISEASE | 4 |
| spain | GPE | 4 |
| netherlands | GPE | 4 |
| amantadine | CHEMICAL | 4 |
| u s | ORG | 4 |
| acute respiratory syndrome sars | DISEASE | 4 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 4 |
| aneurysmal sah | DISEASE | 4 |
| antiphospholipid | DISEASE | 4 |
| autoimmunity | DISEASE | 4 |
| cognitive decline | DISEASE | 4 |
| coma | DISEASE | 4 |
| nd | GPE | 4 |
| nihss | DISEASE | 4 |
| dementia | ORG | 4 |
| mao | PERSON | 4 |
| mnd | ORG | 4 |
| coronavirus infected pneumonia | DISEASE | 4 |
| ap | CHEMICAL | 4 |
| acute stroke | DISEASE | 4 |
| anxiety | DISEASE | 4 |
| bergamo | GPE | 4 |
| cm | ORG | 4 |
| covid19 | ORG | 4 |
| csf igg | ORG | 4 |
| comorbidity | DISEASE | 4 |
| covid 19 disease | DISEASE | 4 |
| diagnosis | GPE | 4 |
| epstein barr | PERSON | 4 |
| guillain barre syndrome | DISEASE | 4 |
| guillain barrè | LOC | 4 |
| guillain barré syndrome | LOC | 4 |
| incidence | ORG | 4 |
| london | GPE | 4 |
| comorbid | DISEASE | 4 |
| lewy | PERSON | 4 |
| creatine | CHEMICAL | 4 |
| neuropathy | DISEASE | 4 |
| myocardial infarction | DISEASE | 4 |
| demyelinating lesions | DISEASE | 4 |
| neurodegenerative diseases | DISEASE | 4 |
| neuroimmunological diseases | DISEASE | 4 |
| neuroinflammation | DISEASE | 4 |
| neurologic syndrome | DISEASE | 4 |
| neurological comorbidity | DISEASE | 4 |
| neurological impairment | DISEASE | 4 |
| peripheral neuropathy | DISEASE | 4 |
| middle east | LOC | 4 |
| renal failure | DISEASE | 4 |
| respiratory distress | DISEASE | 4 |
| rituximab | CHEMICAL | 4 |
| steroids | CHEMICAL | 4 |
| tetraparesis | DISEASE | 4 |
| tissue damage | DISEASE | 4 |
| transverse myelitis | DISEASE | 4 |
| tumors | DISEASE | 4 |
| muscle weakness | DISEASE | 4 |
| respiratory distress syndrome | DISEASE | 4 |
| meningitis encephalitis | DISEASE | 4 |
| fingolimod | CHEMICAL | 4 |
| meningitis | DISEASE | 4 |
| depression anxiety | DISEASE | 4 |
| depressive | DISEASE | 4 |
| dopamine | CHEMICAL | 4 |
| encephalomyelitis | DISEASE | 4 |
| epilepsy | DISEASE | 4 |
| facial weakness | DISEASE | 4 |
| fatigue | DISEASE | 4 |
| dysgeusia | DISEASE | 4 |
| gliomas | PERSON | 4 |
| hyperintensity | DISEASE | 4 |
| infectious disease | DISEASE | 4 |
| interstitial pneumonia | DISEASE | 4 |
| intracranial hemorrhage | DISEASE | 4 |
| lactate | CHEMICAL | 4 |
| hemorrhagic stroke | DISEASE | 4 |
| malignancy | DISEASE | 4 |
| odor | GPE | 3 |
| qol | GPE | 3 |
| prognosis | ORG | 3 |
| prevalence | ORG | 3 |
| parkinson s disease | DISEASE | 3 |
| org | CHEMICAL | 3 |
| neuromuscular | ORG | 3 |
| oi impairment | CHEMICAL | 3 |
| northern italy | LOC | 3 |
| njd | CHEMICAL | 3 |
| marco | CHEMICAL | 3 |
| sf 12 | ORG | 3 |
| manousakis | PERSON | 3 |
| romagnolo | PERSON | 3 |
| written | PERSON | 3 |
| scotland | GPE | 3 |
| tnf | ORG | 3 |
| table 1 | LOC | 3 |
| th9 | CHEMICAL | 3 |
| u l | ORG | 3 |
| viral | TAXON | 3 |
| who | ORG | 3 |
| wilcoxon | ORG | 3 |
| zambon | PERSON | 3 |
| asyn | ORG | 3 |
| animals | TAXON | 3 |
| aphasia | LOC | 3 |
| mds | ORG | 3 |
| msw | ORG | 3 |
| characteristics | ORG | 3 |
| mca | ORG | 3 |
| fisher syndrome | DISEASE | 3 |
| acute | PERSON | 3 |
| anxiety depression | CHEMICAL | 3 |
| asan medical center | ORG | 3 |
| brain | GPE | 3 |
| cga | ORG | 3 |
| cta | ORG | 3 |
| california | GPE | 3 |
| cardiovascular | ORG | 3 |
| atherosclerosis | GPE | 3 |
| d68 | ORG | 3 |
| ed | ORG | 3 |
| emd | ORG | 3 |
| fisher syndrome | DISEASE | 3 |
| lichtblau | PERSON | 3 |
| germany | GPE | 3 |
| glasgow | GPE | 3 |
| head injury | DISEASE | 3 |
| headache | ORG | 3 |
| human | TAXON | 3 |
| ip | ORG | 3 |
| irr | ORG | 3 |
| japan | GPE | 3 |
| k b | CHEMICAL | 3 |
| kruskal wallis | ORG | 3 |
| lvo stroke | DISEASE | 3 |
| lack | PERSON | 3 |
| artery ischaemic stroke | DISEASE | 3 |
| parkinson disease | DISEASE | 3 |
| bacteremia | DISEASE | 3 |
| myasthenia gravis | DISEASE | 3 |
| neuroimmunological disorders | DISEASE | 3 |
| neurological sequalae | DISEASE | 3 |
| neurological syndrome | DISEASE | 3 |
| neuromuscular disorders | DISEASE | 3 |
| organ failure | DISEASE | 3 |
| pain | DISEASE | 3 |
| primary malignant | DISEASE | 3 |
| primary malignant brain tumors | DISEASE | 3 |
| primary stroke | DISEASE | 3 |
| pulmonary infarction | DISEASE | 3 |
| radicular pain | DISEASE | 3 |
| respiratory illness | DISEASE | 3 |
| respiratory syndrome coronavirus | DISEASE | 3 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 3 |
| respiratory syndrome coronavirus infection | DISEASE | 3 |
| rhabdomyolysis | DISEASE | 3 |
| ruptured aneurysms | DISEASE | 3 |
| symptomatology | DISEASE | 3 |
| thromboembolic | DISEASE | 3 |
| thrombosis | DISEASE | 3 |
| thrombus | DISEASE | 3 |
| tick | TAXON | 3 |
| trauma | DISEASE | 3 |
| vascular comorbidities | DISEASE | 3 |
| vasculitis | DISEASE | 3 |
| vessel occlusion | DISEASE | 3 |
| bacteria | TAXON | 3 |
| nasal obstruction | DISEASE | 3 |
| shock | DISEASE | 3 |
| muscular injury | DISEASE | 3 |
| gustatory dysfunction | DISEASE | 3 |
| cardiovascular disease | DISEASE | 3 |
| muscle mass loss | DISEASE | 3 |
| central nervous system infection | DISEASE | 3 |
| cerebral hemorrhage | DISEASE | 3 |
| circulation infarctions | DISEASE | 3 |
| confusional | DISEASE | 3 |
| coronavirus pneumonia | DISEASE | 3 |
| diabetes mellitus | DISEASE | 3 |
| diarrhea | DISEASE | 3 |
| encephalopathic | DISEASE | 3 |
| endothelial dysfunction | DISEASE | 3 |
| expectoration | DISEASE | 3 |
| facial diplegia | DISEASE | 3 |
| coronavirus sars | DISEASE | 3 |
| head injury | DISEASE | 3 |
| hypesthesia | ORG | 3 |
| journal | ORG | 3 |
| lymphocytopenia | DISEASE | 3 |
| hematologic malignancies | DISEASE | 3 |
| infectious diseases | DISEASE | 3 |
| impaired consciousness | DISEASE | 3 |
| illness neuropathy | DISEASE | 3 |
| hydroxychloroquine | CHEMICAL | 3 |
| human coronavirus oc43 | DISEASE | 3 |
| human coronavirus | TAXON | 3 |
| hepatitis e | DISEASE | 3 |
| na | ORG | 2 |
| nnr | ORG | 2 |
| myopathy | DISEASE | 2 |
| ncse | ORG | 2 |
| ndc | ORG | 2 |
| nih | ORG | 2 |
| mycoplasma pneumoniae | PERSON | 2 |
| ninds | DISEASE | 2 |
| nmosd | DISEASE | 2 |
| neuro covid | PERSON | 2 |
| np | ORG | 2 |
| national health commission | ORG | 2 |
| national ms society | ORG | 2 |
| neurocompass | ORG | 2 |
| neurotrauma | ORG | 2 |
| neurological comorbidities | DISEASE | 2 |
| multiple sclerosis ms | ORG | 2 |
| neurological symptoms | DISEASE | 2 |
| neurological comorbidity | DISEASE | 2 |
| mycobacterium | TAXON | 2 |
| mpa | ORG | 2 |
| miller fisher syndrome | DISEASE | 2 |
| miller fisher | PERSON | 2 |
| lu | PERSON | 2 |
| neuropathy crimyne | ORG | 2 |
| lung cancer | PERSON | 2 |
| maf | ORG | 2 |
| methods retrospective | ORG | 2 |
| mgr | ORG | 2 |
| ml | PERSON | 2 |
| mra | ORG | 2 |
| ms dmt | ORG | 2 |
| msis | ORG | 2 |
| msfocused | PERSON | 2 |
| mz | ORG | 2 |
| maike | CHEMICAL | 2 |
| mann whitney u | PERSON | 2 |
| medical research council | ORG | 2 |
| medtronic | ORG | 2 |
| miller | PERSON | 2 |
| neuropathy | DISEASE | 2 |
| studies | ORG | 2 |
| new york | GPE | 2 |
| saxony germany | GPE | 2 |
| sepsis | DISEASE | 2 |
| sicily | GPE | 2 |
| sigma taufkirchen frg | PERSON | 2 |
| spinal | ORG | 2 |
| studi | PERSON | 2 |
| subarachnoid aneurysm | DISEASE | 2 |
| sudre carole | PERSON | 2 |
| symptoms | ORG | 2 |
| tia | ORG | 2 |
| the institutional review board | ORG | 2 |
| thrombectomy | PERSON | 2 |
| thrombolysis | DISEASE | 2 |
| toscana | GPE | 2 |
| università degli studi di | CHEMICAL | 2 |
| u s a | CHEMICAL | 2 |
| ulrik | DISEASE | 2 |
| laird | PERSON | 2 |
| seoul republic | GPE | 2 |
| suvr | ORG | 2 |
| new york city | GPE | 2 |
| spss | ORG | 2 |
| norgine | GPE | 2 |
| novartis | GPE | 2 |
| olfactory deficits | DISEASE | 2 |
| pca | ORG | 2 |
| pdm | ORG | 2 |
| pica | ORG | 2 |
| parkinsonism | DISEASE | 2 |
| peter | DISEASE | 2 |
| pharmacia freiburg | PERSON | 2 |
| procalcitonin | PERSON | 2 |
| pubmed and ovid medline | ORG | 2 |
| rbd | ORG | 2 |
| rna | ORG | 2 |
| radiologic | GPE | 2 |
| sars cov infection | DISEASE | 2 |
| sarscov 2 | TAXON | 2 |
| sma | ORG | 2 |
| li | CHEMICAL | 2 |
| ace 2 | ORG | 2 |
| laboratory | ORG | 2 |
| babinski | ORG | 2 |
| barre syndrome | DISEASE | 2 |
| belgium | GPE | 2 |
| bickerstaff | ORG | 2 |
| biogen idec | ORG | 2 |
| blood | ORG | 2 |
| brain ct | ORG | 2 |
| brescia province | GPE | 2 |
| c02 | ORG | 2 |
| cd163 | CHEMICAL | 2 |
| cmv | TAXON | 2 |
| co2 | PERSON | 2 |
| conclusions | ORG | 2 |
| covid 19 covid 19 | ORG | 2 |
| covid 19 concomitant | ORG | 2 |
| covid 19 neuropsychiatric | ORG | 2 |
| crimyne | ORG | 2 |
| crs | ORG | 2 |
| bannwarth s syndrome | DISEASE | 2 |
| bmi finally | ORG | 2 |
| chalabi | CHEMICAL | 2 |
| bm | ORG | 2 |
| west nile virus | LOC | 2 |
| 4 9 | CHEMICAL | 2 |
| 5wpx0bd0 | CHEMICAL | 2 |
| acs | ORG | 2 |
| aor | ORG | 2 |
| abbvie | ORG | 2 |
| acute necrotizing encephalopathy | DISEASE | 2 |
| ahmed idbaih | PERSON | 2 |
| al chalabi | PERSON | 2 |
| alzheimer | DISEASE | 2 |
| angiotensin | CHEMICAL | 2 |
| antiganglioside | CHEMICAL | 2 |
| appendix | GPE | 2 |
| asbury | ORG | 2 |
| asia | LOC | 2 |
| associations | ORG | 2 |
| atrophy | ORG | 2 |
| cerebrovascular disease | DISEASE | 2 |
| coagulopathy | DISEASE | 2 |
| lo | ORG | 2 |
| hiv hiv | TAXON | 2 |
| hippocampal | ORG | 2 |
| horowitz | PERSON | 2 |
| human coronaviruses | TAXON | 2 |
| hypertension | DISEASE | 2 |
| hypothermia | PERSON | 2 |
| idh | ORG | 2 |
| ii | ORG | 2 |
| irb | ORG | 2 |
| igg igm | ORG | 2 |
| interstitial pneumonia | ORG | 2 |
| intracerebral hemorrhage | DISEASE | 2 |
| italy comorbidity | GPE | 2 |
| jak | ORG | 2 |
| jc | GPE | 2 |
| jyc | CHEMICAL | 2 |
| koffijberg | GPE | 2 |
| korea | GPE | 2 |
| havenon | DISEASE | 2 |
| guillaine barrè | LOC | 2 |
| community | DISEASE | 2 |
| guillain barrè syndrome | DISEASE | 2 |
| consensus | PERSON | 2 |
| corticosteroid | GPE | 2 |
| cuffaro | GPE | 2 |
| delpech | PERSON | 2 |
| dersimonian | ORG | 2 |
| dexamethasone | CHEMICAL | 2 |
| ecm | ORG | 2 |
| electronic supplementary material | PERSON | 2 |
| evt | ORG | 2 |
| encephalitis | PERSON | 2 |
| encephalopathy syndrome pres | DISEASE | 2 |
| england | GPE | 2 |
| fatigue | ORG | 2 |
| fio | CHEMICAL | 2 |
| france | GPE | 2 |
| gm | ORG | 2 |
| glioblastoma | GPE | 2 |
| west nile | LOC | 2 |
| oi deficits | DISEASE | 2 |
| wiesch | GPE | 2 |
| polyradiculoneuropathy | DISEASE | 2 |
| paraparesis | DISEASE | 2 |
| pathologies | DISEASE | 2 |
| paucisymptomatic infections | DISEASE | 2 |
| penicillin | CHEMICAL | 2 |
| penicillin g | PERSON | 2 |
| peripheral facial diplegia | DISEASE | 2 |
| peripheral facial nerve palsy | DISEASE | 2 |
| peripheral nervous system disorders | DISEASE | 2 |
| primary spinal epidural abscess | DISEASE | 2 |
| lymphomeningoradiculitis | GPE | 2 |
| psychiatric | DISEASE | 2 |
| pulmonary disease | DISEASE | 2 |
| pyogenic infection | DISEASE | 2 |
| quadriparetic | DISEASE | 2 |
| rabbit | TAXON | 2 |
| rats | TAXON | 2 |
| respiratory disease | DISEASE | 2 |
| respiratory muscle rigidity | DISEASE | 2 |
| oligodendroglioma | GPE | 2 |
| olfactory and gustatory disorders | DISEASE | 2 |
| oculomotor nerve palsy | DISEASE | 2 |
| ocrelizumab | DISEASE | 2 |
| mmhg | ORG | 2 |
| multiple sclerosis ms | DISEASE | 2 |
| mumps meningitis | DISEASE | 2 |
| muscle atrophy | DISEASE | 2 |
| muscle injury | DISEASE | 2 |
| myoclonus | DISEASE | 2 |
| neoplastic diseases | DISEASE | 2 |
| neuroimmune diseases | DISEASE | 2 |
| neurologic comorbidities | DISEASE | 2 |
| neurological deterioration | DISEASE | 2 |
| neurological manifestations especially olfactory and gustatory dysfunction | DISEASE | 2 |
| neurological sequelae | DISEASE | 2 |
| neuromyelitis optica | DISEASE | 2 |
| neuromyelitis optica spectrum disorder nmosd | DISEASE | 2 |
| neuromyelitis optica spectrum disorders | DISEASE | 2 |
| neuropsychiatric sequelae | DISEASE | 2 |
| nucleic acid | CHEMICAL | 2 |
| respiratory symptoms | DISEASE | 2 |
| respiratory syndrome mers | DISEASE | 2 |
| respiratory syndrome coronavirus mers | DISEASE | 2 |
| thoracic | GPE | 2 |
| thrombocytopenic purpura | DISEASE | 2 |
| toxicity | DISEASE | 2 |
| trunk instability | DISEASE | 2 |
| ucl | ORG | 2 |
| varicella zoster meningoencephalitis | DISEASE | 2 |
| vasogenic edema | DISEASE | 2 |
| vein thrombosis | DISEASE | 2 |
| vessel ischemic stroke | DISEASE | 2 |
| vessel stroke guillain barre syndrome | DISEASE | 2 |
| viral anosmia | DISEASE | 2 |
| viral disease | DISEASE | 2 |
| viral encephalitis | DISEASE | 2 |
| viral genome | TAXON | 2 |
| vitamin b12 | CHEMICAL | 2 |
| weakness | DISEASE | 2 |
| white matter hyperintensity | DISEASE | 2 |
| youngerman | TAXON | 2 |
| thrombi | DISEASE | 2 |
| the institutional review board of | ORG | 2 |
| rupture | DISEASE | 2 |
| the world health organization | ORG | 2 |
| ruptured aneurysm | DISEASE | 2 |
| shortness of breath | DISEASE | 2 |
| skeletal muscle injury | DISEASE | 2 |
| smell dysfunction | DISEASE | 2 |
| spinal abscess | DISEASE | 2 |
| stress anxiety | DISEASE | 2 |
| stroke stroke | DISEASE | 2 |
| strokes nihss | DISEASE | 2 |
| subdural hematomas | DISEASE | 2 |
| swab | PERSON | 2 |
| the american academy of neurology | ORG | 2 |
| the french intensive care society institutional review board ce srlf | ORG | 2 |
| the mrc national survey of health and development | ORG | 2 |
| the neuromuscular clinic of palermo | ORG | 2 |
| the preferred reporting items for systematic reviews | ORG | 2 |
| the u s | GPE | 2 |
| zrvykzof | CHEMICAL | 2 |
| mig | TAXON | 2 |
| the united states | GPE | 2 |
| lymphocytic meningoradiculitis bannwarth s syndrome | DISEASE | 2 |
| autoimmune diseases | DISEASE | 2 |
| bacterial superinfection | DISEASE | 2 |
| bacterium | TAXON | 2 |
| bleed | DISEASE | 2 |
| brainstem dysfunction | DISEASE | 2 |
| cardioembolic stroke | DISEASE | 2 |
| ceftriaxone | CHEMICAL | 2 |
| cerebrovascular and alzheimer s disease | DISEASE | 2 |
| chronic dysimmune neuropathies | DISEASE | 2 |
| chronic illness | DISEASE | 2 |
| chronic subdural hematoma | DISEASE | 2 |
| circulation stroke | DISEASE | 2 |
| cladribine | CHEMICAL | 2 |
| claustrum lesions | DISEASE | 2 |
| confusion | DISEASE | 2 |
| cord_uid | ORG | 2 |
| corona virus disease | DISEASE | 2 |
| coronavirus 2019 covid | DISEASE | 2 |
| autoimmune epilepsy | DISEASE | 2 |
| atherosclerotic | DISEASE | 2 |
| coronavirus covid | DISEASE | 2 |
| aspartate | CHEMICAL | 2 |
| aciclovir | PERSON | 2 |
| lung cancer | DISEASE | 2 |
| acute flaccid myelitis | DISEASE | 2 |
| acute flaccid paralysis | DISEASE | 2 |
| acute infection | DISEASE | 2 |
| acute motor axonal neuropathy | DISEASE | 2 |
| acute motor axonal neuropathy aman | DISEASE | 2 |
| acute necrotizing encephalopathy | DISEASE | 2 |
| acute necrotizing hemorrhagic encephalopathy | DISEASE | 2 |
| acute respiratory syndrome coronavirus 2 infection | DISEASE | 2 |
| acute stroke ischemic | DISEASE | 2 |
| alemtuzumab | CHEMICAL | 2 |
| aneurysm | DISEASE | 2 |
| aneurysmal subarachnoid hemorrhage | DISEASE | 2 |
| anoxic | DISEASE | 2 |
| anuria | GPE | 2 |
| artery disease | DISEASE | 2 |
| coronavirus 2019 ncov | DISEASE | 2 |
| alanine | CHEMICAL | 2 |
| coronavirus sars cov 2 outside of wuhan china retrospective | DISEASE | 2 |
| hypoxia | DISEASE | 2 |
| herpes simplex virus varicella zoster | DISEASE | 2 |
| herpetic encephalitis | DISEASE | 2 |
| host | TAXON | 2 |
| human neural cell | TAXON | 2 |
| hydrocephalus | DISEASE | 2 |
| hypercoagulability | DISEASE | 2 |
| hypercytokinaemia | DISEASE | 2 |
| hypertension diabetes mellitus | DISEASE | 2 |
| immunocompromised | DISEASE | 2 |
| hemorrhagic strokes | DISEASE | 2 |
| impairment of the respiratory system clinicians | DISEASE | 2 |
| infarcts | DISEASE | 2 |
| infection guillain | DISEASE | 2 |
| intracerebral haematomas | DISEASE | 2 |
| intravascular coagulation | DISEASE | 2 |
| coronavirus infection | DISEASE | 2 |
| ischemic strokes | DISEASE | 2 |
| ischemia | DISEASE | 2 |
| heparin | CHEMICAL | 2 |
| infarct | DISEASE | 2 |
| hemorrhage | DISEASE | 2 |
| edema | DISEASE | 2 |
| creatinine | CHEMICAL | 2 |
| gliomas hgg | PERSON | 2 |
| coronaviruses | TAXON | 2 |
| dementias | DISEASE | 2 |
| coronaviruses 229e | DISEASE | 2 |
| disability | DISEASE | 2 |
| dry cough | DISEASE | 2 |
| dysautonomia | DISEASE | 2 |
| dexamethasone | CHEMICAL | 2 |
| encephalopathy pres | DISEASE | 2 |
| epileptic | DISEASE | 2 |
| glioblastoma | DISEASE | 2 |
| folate | CHEMICAL | 2 |
| failure | DISEASE | 2 |
| endothelial damage | DISEASE | 2 |
| encephalopathy syndrome pres | DISEASE | 2 |
| multi | GPE | 1 |
| multiple deprivation simd | ORG | 1 |
| multiple sclerosis | ORG | 1 |
| multiple sclerosis | DISEASE | 1 |
| mr kumar | PERSON | 1 |
| multivariable | ORG | 1 |
| mumps | PERSON | 1 |
| mumps meningitis | DISEASE | 1 |
| musculoskeletal | GPE | 1 |
| musculoskeletal infections | DISEASE | 1 |
| myalgia | DISEASE | 1 |
| ms gazdag | PERSON | 1 |
| mycobacterium tuberculosis | CHEMICAL | 1 |
| nshd | ORG | 1 |
| myelitis | DISEASE | 1 |
| nchs | ORG | 1 |
| nice | ORG | 1 |
| nimv | CHEMICAL | 1 |
| nmds | DISEASE | 1 |
| nr ms | ORG | 1 |
| nancy b | DISEASE | 1 |
| nancy b moore | PERSON | 1 |
| nancy d chiaravalloti | PERSON | 1 |
| nasopharyngeal sars | DISEASE | 1 |
| natalizumab | CHEMICAL | 1 |
| national institute for health research nihr | ORG | 1 |
| national institute of health stroke scale | ORG | 1 |
| moreno falini andrea | PERSON | 1 |
| national institute for health and clinical excellence | ORG | 1 |
| movement disorder | DISEASE | 1 |
| medtronic ucb pharma | ORG | 1 |
| morassi | CHEMICAL | 1 |
| medtronic zambon pharma | PERSON | 1 |
| matilde | CHEMICAL | 1 |
| national research ethics service committee | ORG | 1 |
| matlab | PERSON | 1 |
| maurizio versino | PERSON | 1 |
| mayo | PERSON | 1 |
| mayo clinic | ORG | 1 |
| mcarthur justin | PERSON | 1 |
| mcdonald | ORG | 1 |
| mechanisms | PERSON | 1 |
| medrhythms | PERSON | 1 |
| medicare | ORG | 1 |
| medicine rating scale | ORG | 1 |
| medicine rating scale quality | ORG | 1 |
| meningeal irritation | DISEASE | 1 |
| moore nancy b | PERSON | 1 |
| mental scale | ORG | 1 |
| merck | ORG | 1 |
| meta | ORG | 1 |
| miami | GPE | 1 |
| michael reinhard matthias | PERSON | 1 |
| microbes | TAXON | 1 |
| mild | GPE | 1 |
| mild cognitive impairment 10 | ORG | 1 |
| mimics | ORG | 1 |
| monocyte | ORG | 1 |
| montalenti | PERSON | 1 |
| montanaro | PERSON | 1 |
| montemurro | CHEMICAL | 1 |
| national institutes of health cecilia meza | ORG | 1 |
| ondine | ORG | 1 |
| needle | ORG | 1 |
| oxford nanopore | ORG | 1 |
| obesity | ORG | 1 |
| oertel matthias f 2012 | PERSON | 1 |
| olfactory | ORG | 1 |
| olfactory and gustatory dysfunctions | DISEASE | 1 |
| olfactory disorders | DISEASE | 1 |
| onset | GPE | 1 |
| organ failure assessment | ORG | 1 |
| otherwise sea | LOC | 1 |
| out of hospital emergency system | ORG | 1 |
| outbreak research council | ORG | 1 |
| ovid embase | PERSON | 1 |
| oxford | ORG | 1 |
| oxford centre for evidence | ORG | 1 |
| oxford university | ORG | 1 |
| op sars | CHEMICAL | 1 |
| pa however | ORG | 1 |
| pacc | CHEMICAL | 1 |
| pcori | ORG | 1 |
| pcr of these covid 19 | ORG | 1 |
| pcr patients | ORG | 1 |
| pd 31 | ORG | 1 |
| pd neurodegeneration | DISEASE | 1 |
| pdmperformed | ORG | 1 |
| pf | ORG | 1 |
| pms study | ORG | 1 |
| pn | GPE | 1 |
| pn 49 | ORG | 1 |
| pnp | CHEMICAL | 1 |
| op sars cov 2 rt | ORG | 1 |
| oc43 axonal | ORG | 1 |
| negative myeloperoxidase | ORG | 1 |
| neuropsychiatric signs | DISEASE | 1 |
| nerve | GPE | 1 |
| neurocrit care | PERSON | 1 |
| neuroimaging | GPE | 1 |
| neurologic manifestations of hospitalized patients with coronavirus | ORG | 1 |
| neurologic complications | DISEASE | 1 |
| neurological disorders | DISEASE | 1 |
| neurology | PERSON | 1 |
| neuromuscular diseases | DISEASE | 1 |
| neuromuscular diseases | DISEASE | 1 |
| neuromuscular disorders | DISEASE | 1 |
| neuropathogenesis | GPE | 1 |
| neuropathological | ORG | 1 |
| neuropsychiatric disturbance | DISEASE | 1 |
| neurosyphilis | GPE | 1 |
| oc43 | ORG | 1 |
| new microbes new | LOC | 1 |
| new york healthcare system | ORG | 1 |
| newcastle | GPE | 1 |
| nico | GPE | 1 |
| nicolas gatulle | PERSON | 1 |
| nicolas weiss | PERSON | 1 |
| nighoghossian | CHEMICAL | 1 |
| none conflicts | PERSON | 1 |
| none written | PERSON | 1 |
| norbert mechtouff laura | PERSON | 1 |
| north central london | ORG | 1 |
| northern california | LOC | 1 |
| notes | PERSON | 1 |
| mateen farrah | PERSON | 1 |
| kikwit ebola | ORG | 1 |
| massis | CHEMICAL | 1 |
| martin | PERSON | 1 |
| jo sungyang chang jun | PERSON | 1 |
| jon stoessl | ORG | 1 |
| jonathan m | PERSON | 1 |
| juan mehta arpan | PERSON | 1 |
| julia rascle lucie | DISEASE | 1 |
| julian friese manuel | PERSON | 1 |
| julien dres | PERSON | 1 |
| julien mayaux | PERSON | 1 |
| k | CHEMICAL | 1 |
| kaplan meier | ORG | 1 |
| katja | CHEMICAL | 1 |
| kearns patrick k | PERSON | 1 |
| keshavan ashvini | PERSON | 1 |
| pns diseases | DISEASE | 1 |
| koch institute | ORG | 1 |
| l cerebrospinal fluid | ORG | 1 |
| lcr | ORG | 1 |
| ldh | ORG | 1 |
| lkb bromma sweden | PERSON | 1 |
| ll | ORG | 1 |
| lmwh | ORG | 1 |
| la fondation | ORG | 1 |
| laboratory abnormalities | DISEASE | 1 |
| lara robertson | PERSON | 1 |
| laser nephelometer | PERSON | 1 |
| lazzarin serena marita | PERSON | 1 |
| lean european survey | ORG | 1 |
| lechien | CHEMICAL | 1 |
| lechien et al | PERSON | 1 |
| jessica de | PERSON | 1 |
| jeremy dalgas | PERSON | 1 |
| jeremy chataway | PERSON | 1 |
| italy neurologic | GPE | 1 |
| interferon | ORG | 1 |
| international mission for prognosis and | ORG | 1 |
| interventional | ORG | 1 |
| intracerebral haemorrhage | DISEASE | 1 |
| intracranial hypertension | DISEASE | 1 |
| intracranial haemorrhage ich | DISEASE | 1 |
| intriguing | ORG | 1 |
| intselchimos | ORG | 1 |
| inversion recovery letm | ORG | 1 |
| isabelle idbaih | PERSON | 1 |
| italy coronavirus | GPE | 1 |
| italy coronavirus disease | DISEASE | 1 |
| italy essential | GPE | 1 |
| italy neurologic manifestations | DISEASE | 1 |
| jeong suyeon | PERSON | 1 |
| italy s | GPE | 1 |
| italy thromboembolic | DISEASE | 1 |
| item | ORG | 1 |
| jd | ORG | 1 |
| jf | GPE | 1 |
| jhm immunoglobulin abnormalities | DISEASE | 1 |
| james sarah | PERSON | 1 |
| japan 9 | ORG | 1 |
| japan mental | ORG | 1 |
| jaqueline | CHEMICAL | 1 |
| jasti madhu | PERSON | 1 |
| jennifer j | PERSON | 1 |
| jeong soo jeon sang beom | PERSON | 1 |
| legionella | TAXON | 1 |
| legionella pneumophila | PERSON | 1 |
| leonardi matilde padovani alessandro | PERSON | 1 |
| maideniuc catalina memon | PERSON | 1 |
| mr | DISEASE | 1 |
| mrc national survey of health and development using | ORG | 1 |
| mri cerebrospinal fluid csf | ORG | 1 |
| mri cervical | ORG | 1 |
| mri imaging | ORG | 1 |
| ms clinics | ORG | 1 |
| ms recent | ORG | 1 |
| ms exacerbations | DISEASE | 1 |
| ms symptomatology | DISEASE | 1 |
| msj | CHEMICAL | 1 |
| mssa | ORG | 1 |
| mvpa | ORG | 1 |
| madhu | CHEMICAL | 1 |
| majoie | PERSON | 1 |
| mk | CHEMICAL | 1 |
| manousakis georgios | PERSON | 1 |
| marc schulze | PERSON | 1 |
| marco ferrero | PERSON | 1 |
| marco giorgi pietro | PERSON | 1 |
| marco mauri | PERSON | 1 |
| marco sessa maria | PERSON | 1 |
| marco sessa maria title neurologic manifestations | CHEMICAL | 1 |
| maria grazia querzani | PERSON | 1 |
| maria la | PERSON | 1 |
| maria pia amato | PERSON | 1 |
| mariarosaria | DISEASE | 1 |
| mario giorgio | PERSON | 1 |
| martens u sticht groh | PERSON | 1 |
| mn908947 | CHEMICAL | 1 |
| mf | GPE | 1 |
| letter covid | DISEASE | 1 |
| lung ct | PERSON | 1 |
| lippi et al | PERSON | 1 |
| logistic | ORG | 1 |
| london hospitals biomedical research centre | ORG | 1 |
| los angeles | GPE | 1 |
| losses of smell and taste | DISEASE | 1 |
| louapre et al | PERSON | 1 |
| lovati et al | PERSON | 1 |
| low molecular | PERSON | 1 |
| lu kirsty | PERSON | 1 |
| lucia filippi massimo | PERSON | 1 |
| lucia princiotta cariddi | PERSON | 1 |
| lucia tabaee | PERSON | 1 |
| lumbar | LOC | 1 |
| lupus sjogren s | ORG | 1 |
| methods cross | ORG | 1 |
| lusofarmaco chiesi farmaceutici medtronic | ORG | 1 |
| lutz wolz | PERSON | 1 |
| lyme disease neurologic abnormalities | DISEASE | 1 |
| lymphocytes | PERSON | 1 |
| lyon | PERSON | 1 |
| lyon csc | PERSON | 1 |
| m coutinho j m | PERSON | 1 |
| mb | PERSON | 1 |
| medline | ORG | 1 |
| mep | ORG | 1 |
| mers cov neurological | ORG | 1 |
| mers cov infection | DISEASE | 1 |
| methods a | ORG | 1 |
| pnp moderate | ORG | 1 |
| rivals | TAXON | 1 |
| pns disorders | DISEASE | 1 |
| sandroff | CHEMICAL | 1 |
| solo and small practices | ORG | 1 |
| spearman | PERSON | 1 |
| specific dmt | PERSON | 1 |
| specificity of csf | ORG | 1 |
| spike | ORG | 1 |
| staph epidermidis | GPE | 1 |
| staphylococcus | LOC | 1 |
| stata version | ORG | 1 |
| statistical | ORG | 1 |
| stefan geissler | PERSON | 1 |
| stefan reichmann | PERSON | 1 |
| steins | CHEMICAL | 1 |
| steroid | PERSON | 1 |
| steroidresponsive | ORG | 1 |
| sticht | CHEMICAL | 1 |
| storti benedetta | PERSON | 1 |
| streptococcus | GPE | 1 |
| streptococcus pneumoniae | ORG | 1 |
| stress anxiety | DISEASE | 1 |
| striatal | ORG | 1 |
| study validity | ORG | 1 |
| subdural hematoma | DISEASE | 1 |
| subgroup | PERSON | 1 |
| supplementary | GPE | 1 |
| surcinelli andrea | PERSON | 1 |
| swen weßendorf | PERSON | 1 |
| syndromic | DISEASE | 1 |
| são paulo | GPE | 1 |
| tbe tick | ORG | 1 |
| soleus h | ORG | 1 |
| social | ORG | 1 |
| smell dysfunction | DISEASE | 1 |
| serologic | ORG | 1 |
| sanofi aventis | PERSON | 1 |
| sarah | PERSON | 1 |
| sars cov 2 | ORG | 1 |
| saudi arabia | GPE | 1 |
| scandroglio | CHEMICAL | 1 |
| schott | PERSON | 1 |
| schubert joerg gueldner | PERSON | 1 |
| sedentary behaviors | DISEASE | 1 |
| seegene inc | PERSON | 1 |
| seizure | DISEASE | 1 |
| sensitivity | ORG | 1 |
| sera | PERSON | 1 |
| serdar | CHEMICAL | 1 |
| serology | PERSON | 1 |
| sina schroettner | PERSON | 1 |
| serva munich frg | PERSON | 1 |
| severe acute respiratory syndrome corona virus sars cov | ORG | 1 |
| severity | GPE | 1 |
| sgarzi | CHEMICAL | 1 |
| shadi | CHEMICAL | 1 |
| shalash | CHEMICAL | 1 |
| shtaya | GPE | 1 |
| sicily region | GPE | 1 |
| siepmann timo sedghi annahita | PERSON | 1 |
| sierra | CHEMICAL | 1 |
| sierra hidalgo fernando muñoz | ORG | 1 |
| simister robert | PERSON | 1 |
| simone | CHEMICAL | 1 |
| tiv | ORG | 1 |
| tm | GPE | 1 |
| tpha | CHEMICAL | 1 |
| usa 8 | ORG | 1 |
| toxoplasma | PERSON | 1 |
| toxoplasma gondii | TAXON | 1 |
| transient | ORG | 1 |
| traumatic | DISEASE | 1 |
| treponema pallidum | TAXON | 1 |
| trobia g 2020 delayed | ORG | 1 |
| tumor | DISEASE | 1 |
| tumors | DISEASE | 1 |
| u preparing | ORG | 1 |
| ucb | ORG | 1 |
| ucb pharma data | ORG | 1 |
| ucl hospitals | ORG | 1 |
| us | GPE | 1 |
| usd | ORG | 1 |
| torino | GPE | 1 |
| usd quality | ORG | 1 |
| udine | ORG | 1 |
| union hospital wuhan | ORG | 1 |
| unique | ORG | 1 |
| united states | GPE | 1 |
| university college london | ORG | 1 |
| university hospital | ORG | 1 |
| unruptured intracranial aneurysms | DISEASE | 1 |
| ursula schmidt | PERSON | 1 |
| v di stefano | PERSON | 1 |
| vdrl | CHEMICAL | 1 |
| vds gb vg ag | ORG | 1 |
| institutional review board | ORG | 1 |
| toscano et al | PERSON | 1 |
| tick | TAXON | 1 |
| tr | GPE | 1 |
| the covid impact interview | ORG | 1 |
| tt | ORG | 1 |
| table 2 | ORG | 1 |
| table 2 protocol | ORG | 1 |
| talamonti g colistra | PERSON | 1 |
| tania quadri stefano riva | PERSON | 1 |
| taste | ORG | 1 |
| technical university | ORG | 1 |
| telemedicine | PERSON | 1 |
| temporal muscle specific disuse atrophy | DISEASE | 1 |
| teodor reuter | PERSON | 1 |
| teva pharmaceutical industries | ORG | 1 |
| tewald friedemann | PERSON | 1 |
| texas 77845 | CHEMICAL | 1 |
| the claustrum sign date 2020 09 03 | ORG | 1 |
| thrombosis | DISEASE | 1 |
| the ethical board of the university of palermo | ORG | 1 |
| the ethics committee of san raffaele scientific institute | ORG | 1 |
| the hospital anxiety depression scale | ORG | 1 |
| the joanna briggs institute | ORG | 1 |
| the lyon stroke center tertiary university | ORG | 1 |
| the multiple sclerosis impact scale | ORG | 1 |
| the neurology department | ORG | 1 |
| the university of pennsylvania smell identification test upsit | ORG | 1 |
| theoretically | GPE | 1 |
| therapy | ORG | 1 |
| thomas d lane christopher | PERSON | 1 |
| thomas helbig | PERSON | 1 |
| thomas tazarourte | PERSON | 1 |
| sandroff brian m salter | PERSON | 1 |
| salsone maria | PERSON | 1 |
| po2 | CHEMICAL | 1 |
| salsone | CHEMICAL | 1 |
| plasma exchange sandoglobulin guillain barré syndrome trial group baseline | ORG | 1 |
| pneumonia 14 | ORG | 1 |
| pneumonia an official clinical practice guideline | ORG | 1 |
| pneumophila | CHEMICAL | 1 |
| preferred reporting items for systematic reviews | ORG | 1 |
| primary pyogenic infection | DISEASE | 1 |
| progressive multiple sclerosis | ORG | 1 |
| projekt deal funding none ethical | ORG | 1 |
| prompt | PERSON | 1 |
| psychiatric symptoms | DISEASE | 1 |
| psychosocial considerations | ORG | 1 |
| pub med | PERSON | 1 |
| pubmed embase | PERSON | 1 |
| pubmed embase cochrane library | ORG | 1 |
| puetz volker | PERSON | 1 |
| pulmonary embolism | DISEASE | 1 |
| qol minimal | ORG | 1 |
| quarantine | PERSON | 1 |
| rb | ORG | 1 |
| rk | CHEMICAL | 1 |
| rna of sars cov 1 | ORG | 1 |
| rs respiratory symptoms like cough | DISEASE | 1 |
| radiopharmaceuticals | TAXON | 1 |
| ralpharma | GPE | 1 |
| ralpharma dr rizzone | DISEASE | 1 |
| rankin | ORG | 1 |
| rascle | PERSON | 1 |
| ravi vogel andre | PERSON | 1 |
| receptor | GPE | 1 |
| pitié | CHEMICAL | 1 |
| peter koch thea | PERSON | 1 |
| peter filippi | PERSON | 1 |
| parkinson s disease movement disorders | DISEASE | 1 |
| pola network | ORG | 1 |
| prisma | PERSON | 1 |
| pablo ryan | PERSON | 1 |
| padroni marina mastrangelo vincenzo asioli | ORG | 1 |
| pain | DISEASE | 1 |
| pal suvankar | PERSON | 1 |
| palermo | GPE | 1 |
| pall k | LOC | 1 |
| panagiotis title neurological manifestations | DISEASE | 1 |
| papa giovanni xxiii hospital | ORG | 1 |
| para | PERSON | 1 |
| paris | GPE | 1 |
| parkinson s disease pd alzheimer disease ad | ORG | 1 |
| pat 1 | PERSON | 1 |
| peter feys | PERSON | 1 |
| pat 2 | PERSON | 1 |
| paterson s | GPE | 1 |
| pathogenic | ORG | 1 |
| payam tabaee damavandi | PERSON | 1 |
| pearson | PERSON | 1 |
| pedro chao kateri | PERSON | 1 |
| pelea | CHEMICAL | 1 |
| pennsylvania | GPE | 1 |
| percy winzer simon von bonin simone moustafa | PERSON | 1 |
| peripheral pns nervous system | ORG | 1 |
| peripheral nerve disease | DISEASE | 1 |
| perry richard banaras | PERSON | 1 |
| peter c | PERSON | 1 |
| regeneron | ORG | 1 |
| rehabilitation unit | ORG | 1 |
| relationships | ORG | 1 |
| sars coronavirus envelope | DISEASE | 1 |
| sars cov 2 multiple | ORG | 1 |
| sars cov 2 and | ORG | 1 |
| sars cov 2 with sars cov | ORG | 1 |
| sars cov sars cov 2 covid 19 | ORG | 1 |
| sars coronavirus 2 acute meningoencephalitis | DISEASE | 1 |
| sars coronavirus 2 covid | DISEASE | 1 |
| sars coronavirus 2 coronaviruses | DISEASE | 1 |
| sars coronavirus 2 meningoencephalitis | DISEASE | 1 |
| sars cov 2 | ORG | 1 |
| sars neurological | ORG | 1 |
| sars neurological complications | DISEASE | 1 |
| sars coronavirus | TAXON | 1 |
| sars coronavirus multiple organ infection | DISEASE | 1 |
| sarscov 2 infection | DISEASE | 1 |
| saps | ORG | 1 |
| sdmt | ORG | 1 |
| sds | ORG | 1 |
| seas | CHEMICAL | 1 |
| sep | ORG | 1 |
| sf | GPE | 1 |
| sf cm cb | ORG | 1 |
| sj jyc | ORG | 1 |
| sml | ORG | 1 |
| stata | ORG | 1 |
| statacorp college | ORG | 1 |
| strokeaha120030335 stroke | PERSON | 1 |
| swi | ORG | 1 |
| sabino ester cerdeira | CHEMICAL | 1 |
| sars cov 2 infection | ORG | 1 |
| sah conversely | ORG | 1 |
| reliability | ORG | 1 |
| riluzole | CHEMICAL | 1 |
| renan barros | PERSON | 1 |
| reninangiotensin | CHEMICAL | 1 |
| repeated csf | ORG | 1 |
| reperfusion | DISEASE | 1 |
| respiratory syndrome | DISEASE | 1 |
| respiratory distress | DISEASE | 1 |
| respiratory failure | DISEASE | 1 |
| responses | ORG | 1 |
| reversible encephalopathy syndrome pres | ORG | 1 |
| riccardini | PERSON | 1 |
| riccardini franco | PERSON | 1 |
| riccardo servalli maria cristina | PERSON | 1 |
| richard gorrie | PERSON | 1 |
| rinkel l a prick j c m slot r e r sombroek n m a | ORG | 1 |
| sa infection | CHEMICAL | 1 |
| rizzone | CHEMICAL | 1 |
| robert walther bjoern wito | PERSON | 1 |
| roberto perrini paolo | PERSON | 1 |
| roberto schiavo | PERSON | 1 |
| robertson | PERSON | 1 |
| roche | ORG | 1 |
| roche dr fox | ORG | 1 |
| roche ulrik dalgas | ORG | 1 |
| romagnolo alberto | PERSON | 1 |
| rosengarten | CHEMICAL | 1 |
| rosengarten bernhard | PERSON | 1 |
| ruptured aneurysm | DISEASE | 1 |
| s10 | ORG | 1 |
| intensive care unit | ORG | 1 |
| bin | PERSON | 1 |
| institutional ethical board | ORG | 1 |
| bilateral | ORG | 1 |
| conclusion neurological | ORG | 1 |
| conclusions neurological | ORG | 1 |
| covid 19 1 | ORG | 1 |
| covid 19 15 | ORG | 1 |
| covid 19 23 | ORG | 1 |
| covid 19 34 | ORG | 1 |
| covid 19 88 6 | ORG | 1 |
| covid 19 abnormal | ORG | 1 |
| covid 19 characteristics of ischaemic | ORG | 1 |
| covid 19 comorbidity | ORG | 1 |
| covid 19 consistency | ORG | 1 |
| covid 19 coronaviruses covs | ORG | 1 |
| covid 19 data | ORG | 1 |
| covid 19 influence | ORG | 1 |
| covid 19 neurologic | ORG | 1 |
| covid 19 olfactory | ORG | 1 |
| covid 19 olfactory and gustatory dysfunctions | DISEASE | 1 |
| covid 19 pathological | ORG | 1 |
| covid 19 psychological | ORG | 1 |
| covid 19 rr | ORG | 1 |
| covid 19 rhabdomyolysis | ORG | 1 |
| covid 19 second | ORG | 1 |
| covid 19 weakness | ORG | 1 |
| covid 19 coronavirus | DISEASE | 1 |
| covid 19 date 2020 08 04 | ORG | 1 |
| covid 19 neurological complications | DISEASE | 1 |
| covid 19 neurological disease | DISEASE | 1 |
| covid 19 pneumonia date 2020 | ORG | 1 |
| covid 19 respiratory infection | DISEASE | 1 |
| cns damage | DISEASE | 1 |
| cmv cytomegalovirus ebv epstein barr virus hsv 1 herpes simplex virus 1 hsv 2 herpes simplex virus 2 hhv 6 human herpes virus 6 hpev human parechovirus vzv varicella zoster | DISEASE | 1 |
| cmv cytomegalovirus ebv epstein barr virus hsv 1 herpes simplex virus | TAXON | 1 |
| brain computerized tomography ct | ORG | 1 |
| biogen idec merck serono | ORG | 1 |
| biogen idec merck serono roche pharmaceutical industries | ORG | 1 |
| biogen idec national multiple sclerosis society consortium of multiple sclerosis centers | ORG | 1 |
| biogen inc conflicts | PERSON | 1 |
| biogen novartis | PERSON | 1 |
| biotech china | LOC | 1 |
| bonavita s et al | PERSON | 1 |
| borrelia treponema | DISEASE | 1 |
| borrelia treponema pallidum campylobacter jejuni mycoplasma | TAXON | 1 |
| borrelia burgdorferi infection | DISEASE | 1 |
| borrelien enzephalomyelitis lyme disease | CHEMICAL | 1 |
| bozzali | CHEMICAL | 1 |
| bracaglia | GPE | 1 |
| brent griffith covid 19 | PERSON | 1 |
| cm cb | DISEASE | 1 |
| brian yaghi | PERSON | 1 |
| brichetto giampaolo chataway | ORG | 1 |
| brown norway bn | LOC | 1 |
| buchanan sarah m parker | PERSON | 1 |
| buchanan s buchanan ucl | GPE | 1 |
| c3 nasopharyngeal sars cov2 rt pcr | ORG | 1 |
| caa | CHEMICAL | 1 |
| cas major | ORG | 1 |
| cc | CHEMICAL | 1 |
| cci | ORG | 1 |
| cg176 subarachnoid haemorrhage | CHEMICAL | 1 |
| cis | ORG | 1 |
| clc | ORG | 1 |
| covid impact | ORG | 1 |
| covid deaths | DISEASE | 1 |
| covid depression anxiety | DISEASE | 1 |
| chongqing | GPE | 1 |
| charité | CHEMICAL | 1 |
| chaumont h | ORG | 1 |
| chi | PERSON | 1 |
| chiaravalloti nancy d amato maria | PERSON | 1 |
| chibbaro | PERSON | 1 |
| chicago il usa studies | ORG | 1 |
| china classification | ORG | 1 |
| china immediate | ORG | 1 |
| china smell | ORG | 1 |
| china study | ORG | 1 |
| china word health organization | ORG | 1 |
| china zika | LOC | 1 |
| cho | CHEMICAL | 1 |
| chronic | ORG | 1 |
| characteristic | ORG | 1 |
| chronic arterial hypertension | DISEASE | 1 |
| chronic neurological disorders | DISEASE | 1 |
| ciccone | PERSON | 1 |
| cipla | GPE | 1 |
| clemenzi alessandro marelli | PERSON | 1 |
| cov 2 igg igm rapid test guillain barré | ORG | 1 |
| cov infections | DISEASE | 1 |
| cochrane library | PERSON | 1 |
| cognitive impairment | DISEASE | 1 |
| cognitive deficits | DISEASE | 1 |
| cohen s kappa | ORG | 1 |
| colombia | GPE | 1 |
| colombia pcr polymerase chain | TAXON | 1 |
| characteristics of | ORG | 1 |
| changsha comorbidity | GPE | 1 |
| covid infection | DISEASE | 1 |
| callegarini claudio foschi matteo | PERSON | 1 |
| csf sars cov 2 | ORG | 1 |
| csf sars cov 2 pcr | ORG | 1 |
| csf sars cov 2 rt | ORG | 1 |
| csf seizure | ORG | 1 |
| csf of sars cov 2 rna | ORG | 1 |
| ct | PERSON | 1 |
| cvd cerebrovascular disease | DISEASE | 1 |
| cvd impaired consciousness | DISEASE | 1 |
| cvd malignancy dementia | DISEASE | 1 |
| cvon dutch heart foundation twin foundation european commission dutch health evaluation | ORG | 1 |
| cxr | ORG | 1 |
| callea | CHEMICAL | 1 |
| callegarini | DISEASE | 1 |
| campylobacter | GPE | 1 |
| cerebrovascular | ORG | 1 |
| campylobacter jejuni | TAXON | 1 |
| campylobacter jejuni infection | DISEASE | 1 |
| cancer | DISEASE | 1 |
| cannizzaro | GPE | 1 |
| carimati | DISEASE | 1 |
| carl gustav | PERSON | 1 |
| carlos augusto senne | PERSON | 1 |
| catalonia | GPE | 1 |
| central | ORG | 1 |
| central cns | ORG | 1 |
| central nervous system | ORG | 1 |
| centre hospitalier | ORG | 1 |
| cerebrospinal fluid csf | ORG | 1 |
| vaccine | GPE | 1 |
| bickerstaff s encephalitis | DISEASE | 1 |
| coma | DISEASE | 1 |
| bianchetti | GPE | 1 |
| ards acute respiratory distress syndrome | DISEASE | 1 |
| asa american society of anaesthesiologists | ORG | 1 |
| asaa | ORG | 1 |
| aspect | ORG | 1 |
| asst papa giovanni xxiii | ORG | 1 |
| ab anti sars cov 2 | ORG | 1 |
| abbvie ethics | ORG | 1 |
| abbvie dr bozzali | PERSON | 1 |
| abnormal | GPE | 1 |
| abnormal coagulation | DISEASE | 1 |
| abnormal eye movement swallowing dysfunction | DISEASE | 1 |
| acute hospital | ORG | 1 |
| acute physiology and chronic health evaluation ii | ORG | 1 |
| acute cerebrovascular disease | DISEASE | 1 |
| aditya | CHEMICAL | 1 |
| advisory board | ORG | 1 |
| agazzi emanuela | CHEMICAL | 1 |
| ahmed demeret sophie | PERSON | 1 |
| akili interactive | ORG | 1 |
| alexandre | GPE | 1 |
| alpe | DISEASE | 1 |
| alpha wasserman | ORG | 1 |
| alsace | ORG | 1 |
| alshaer dr | PERSON | 1 |
| alshaer qasem | CHEMICAL | 1 |
| altona diagnostics | PERSON | 1 |
| alzheimer disease | DISEASE | 1 |
| alzheimer dementia | DISEASE | 1 |
| alzheimer disease | DISEASE | 1 |
| ards pao | ORG | 1 |
| arc | CHEMICAL | 1 |
| ar | ORG | 1 |
| ace 2 a | CHEMICAL | 1 |
| 10045 9 sha | CHEMICAL | 1 |
| 1580 nucleotide | CHEMICAL | 1 |
| 262598 | DISEASE | 1 |
| 263363 cord_uid | CHEMICAL | 1 |
| 3 4 5 8 | CHEMICAL | 1 |
| 4 0 covid | CHEMICAL | 1 |
| 5014 | DISEASE | 1 |
| 6 right mca n 6 left internal carotid artery ica n 2 right ica n 2 left common carotid artery n 1 basilar artery n 1 left vertebral | CHEMICAL | 1 |
| 6 sha 740a3f675d60f8350a0a7111e6343c509531fa7f | CHEMICAL | 1 |
| 8 mao et al | PERSON | 1 |
| 9340 | CHEMICAL | 1 |
| 9r443j3l | DISEASE | 1 |
| ace | ORG | 1 |
| ace 2 in skeletal muscle 40 however | CHEMICAL | 1 |
| aor 1 78 95 | ORG | 1 |
| ace 2 protein which | CHEMICAL | 1 |
| ace2 | PERSON | 1 |
| ad 1 | ORG | 1 |
| ad clinically | ORG | 1 |
| ad olfactory | ORG | 1 |
| ad neurodegeneration | DISEASE | 1 |
| af | ORG | 1 |
| ag mda | CHEMICAL | 1 |
| aidp following | ORG | 1 |
| ais | ORG | 1 |
| aman | DISEASE | 1 |
| aman csf | ORG | 1 |
| ane | ORG | 1 |
| alzheimer disease delirium | DISEASE | 1 |
| alzheimer s disease | DISEASE | 1 |
| alzheimer s diseaselike dementia | DISEASE | 1 |
| bacterial infections | DISEASE | 1 |
| avid radiopharmaceuticals biogen eli lilly research laboratories | ORG | 1 |
| axon neuroscience roche eli lilly general electric healthcare merck | ORG | 1 |
| azadyne | ORG | 1 |
| b 40 kluver barrera | CHEMICAL | 1 |
| bal | ORG | 1 |
| bal pao 2 fio 2 | ORG | 1 |
| bbb | ORG | 1 |
| bdi | ORG | 1 |
| bf | GPE | 1 |
| bl | ORG | 1 |
| bm ni | ORG | 1 |
| bs | ORG | 1 |
| bacteremia | DISEASE | 1 |
| baltimore | PERSON | 1 |
| authors | ORG | 1 |
| bannwarth | PERSON | 1 |
| barbara gerevini | PERSON | 1 |
| barcelona impact | ORG | 1 |
| barlinn kristian title association of history | ORG | 1 |
| barre | PERSON | 1 |
| barre syndrome gbs | DISEASE | 1 |
| barrientos rmthe | ORG | 1 |
| barré syndrome | PERSON | 1 |
| barré syndrome | DISEASE | 1 |
| based | GPE | 1 |
| baseline | ORG | 1 |
| bayer schering | PERSON | 1 |
| beth de felici | PERSON | 1 |
| autoimmune meningoencephalitis | DISEASE | 1 |
| austria | GPE | 1 |
| alzheimer s deaths | DISEASE | 1 |
| antigenspecific | ORG | 1 |
| alzheimer s p 0 126 | DISEASE | 1 |
| amber cutter | PERSON | 1 |
| amsterdam the | GPE | 1 |
| andrea d aleo | PERSON | 1 |
| andrew nicholas jennifer cash david m malone ian b coath william | PERSON | 1 |
| aneurysm | PERSON | 1 |
| aneurysm trial | PERSON | 1 |
| aneurysm occlusion | DISEASE | 1 |
| angelone v | CHEMICAL | 1 |
| anna mara | PERSON | 1 |
| annahita | DISEASE | 1 |
| anthony saul | PERSON | 1 |
| anti sars cov | ORG | 1 |
| antiphospholipid | DISEASE | 1 |
| asioli | CHEMICAL | 1 |
| antonella | CHEMICAL | 1 |
| antonini et al | PERSON | 1 |
| antonini et al 11 | PERSON | 1 |
| anxiety depression | DISEASE | 1 |
| anza b title acute necrotizing myelitis | CHEMICAL | 1 |
| anzalone | CHEMICAL | 1 |
| apoe4 | ORG | 1 |
| aquaporin 4 | PERSON | 1 |
| articles | PERSON | 1 |
| artusi | PERSON | 1 |
| artusi carlo | PERSON | 1 |
| asan medical center ethics | ORG | 1 |
| asia europe | LOC | 1 |
| columbia university irving medical center | ORG | 1 |
| comatose | DISEASE | 1 |
| insight 46 university of pennsylvania | ORG | 1 |
| fox s | ORG | 1 |
| gigli s | PERSON | 1 |
| giorgianni | CHEMICAL | 1 |
| giuseppe | PERSON | 1 |
| gklinos panagiotis | PERSON | 1 |
| glasgow coma scale | ORG | 1 |
| gomez pinedo et al | PERSON | 1 |
| grrr | PERSON | 1 |
| guan | PERSON | 1 |
| guillain barr6 syndrome | DISEASE | 1 |
| guillain barre syndrome gbs | DISEASE | 1 |
| guillainbarré | ORG | 1 |
| guillan barré | PERSON | 1 |
| h1n1 | GPE | 1 |
| h1n1 infection | DISEASE | 1 |
| h1n1 influenza | PERSON | 1 |
| hads anxiety | ORG | 1 |
| hcov oc43 infection | DISEASE | 1 |
| hev | ORG | 1 |
| hiv rna | TAXON | 1 |
| hiv associated tumefactive demyelinating lesions | DISEASE | 1 |
| hiv infection | DISEASE | 1 |
| ho | DISEASE | 1 |
| hpev human parechovirus | TAXON | 1 |
| hsv 1 encephalitis | DISEASE | 1 |
| hadden | PERSON | 1 |
| harvard | ORG | 1 |
| harzallah et al | PERSON | 1 |
| harzallah et al 25 | PERSON | 1 |
| hassan ruprecht bertram stellbrink | PERSON | 1 |
| gigli gian luigi bax | PERSON | 1 |
| gigli | ORG | 1 |
| gian maria pavolucci lucia abu rumeileh samir | PERSON | 1 |
| gcp | ORG | 1 |
| francesco marini | PERSON | 1 |
| friedrich elias hamp birte heesen | PERSON | 1 |
| frigeni | CHEMICAL | 1 |
| friuli venezia giulia | PERSON | 1 |
| front line | ORG | 1 |
| funding none conflicts | PERSON | 1 |
| g battaglia | PERSON | 1 |
| g m | PERSON | 1 |
| g q a | CHEMICAL | 1 |
| gb analysis | ORG | 1 |
| gbs csf rt pcr | ORG | 1 |
| gbs estimated | ORG | 1 |
| gc | ORG | 1 |
| gd1b | CHEMICAL | 1 |
| ghannam malik alshaer | PERSON | 1 |
| gos | ORG | 1 |
| gabriele ceravolo | PERSON | 1 |
| gary feinstein anthony | PERSON | 1 |
| gaus et al | PERSON | 1 |
| gender | PERSON | 1 |
| genefinder covid 19 | ORG | 1 |
| geneva world health organization acknowledgements open access | ORG | 1 |
| genzyme john deluca | PERSON | 1 |
| george morrison ian carod | PERSON | 1 |
| geriatric | PERSON | 1 |
| germany 10 | GPE | 1 |
| ghannam | ORG | 1 |
| ghannam dr alshaer | PERSON | 1 |
| havenon adam | PERSON | 1 |
| head injury | DISEASE | 1 |
| health | ORG | 1 |
| idec merck serono novartis roche sanofi genzyme | ORG | 1 |
| il 8 | ORG | 1 |
| impact international mission for prognosis and | ORG | 1 |
| inr ptt igg iga igm | ORG | 1 |
| ios a cox | PERSON | 1 |
| ios aphasia | PERSON | 1 |
| ios cardiovascular | ORG | 1 |
| ios furthermore | ORG | 1 |
| ios ios | ORG | 1 |
| ios patients | ORG | 1 |
| ios positive | ORG | 1 |
| ios stroke | PERSON | 1 |
| iv | ORG | 1 |
| ivt 28 vs 30 | ORG | 1 |
| igg sars cov 2 | ORG | 1 |
| icu | DISEASE | 1 |
| igg of csf | ORG | 1 |
| illness myopathy | PERSON | 1 |
| imbalzano | PERSON | 1 |
| imbalzano gabriele ciccone | PERSON | 1 |
| immediately | PERSON | 1 |
| immunotherapy | ORG | 1 |
| impact of covid 19 | ORG | 1 |
| incidental | ORG | 1 |
| independent | ORG | 1 |
| infections | DISEASE | 1 |
| infectious disease | DISEASE | 1 |
| infectious diseases society of america american thoracic society | ORG | 1 |
| insight | ORG | 1 |
| iii | ORG | 1 |
| ichs | DISEASE | 1 |
| health qual life outcomes validation | ORG | 1 |
| herpes simplex virus 2 hhv 6 human | TAXON | 1 |
| heesen christoph | DISEASE | 1 |
| heidi wong | PERSON | 1 |
| helmes | PERSON | 1 |
| helms et al mri | GPE | 1 |
| hematological | PERSON | 1 |
| hemorrhagic | DISEASE | 1 |
| henriksson et al 8 | ORG | 1 |
| heparin | CHEMICAL | 1 |
| hepatitis e | DISEASE | 1 |
| herein | ORG | 1 |
| herman | PERSON | 1 |
| herpes simplex | DISEASE | 1 |
| herpes virus | PERSON | 1 |
| hoffmann la roche | ORG | 1 |
| ich coagulopathy | DISEASE | 1 |
| hong kong | GPE | 1 |
| hosts | ORG | 1 |
| hsiao et al | PERSON | 1 |
| hubei china | ORG | 1 |
| human coronaviruses | ORG | 1 |
| human coronaviruses viral | DISEASE | 1 |
| hydroxychloroquine | CHEMICAL | 1 |
| hypercoagulation | ORG | 1 |
| hypoxia | GPE | 1 |
| hz | ORG | 1 |
| hôpital | ORG | 1 |
| ibm corp armonk ny usa | ORG | 1 |
| ich patients | ORG | 1 |
| frailty | DISEASE | 1 |
| forgotten | LOC | 1 |
| comitato etico interaziendale aou città | ORG | 1 |
| forest | ORG | 1 |
| dmt 5 | ORG | 1 |
| ds | PERSON | 1 |
| ds vh | ORG | 1 |
| dwi | ORG | 1 |
| dwi t2 | ORG | 1 |
| darryl | CHEMICAL | 1 |
| darryl solochek | PERSON | 1 |
| david häußler | PERSON | 1 |
| david j | PERSON | 1 |
| davide crisà | CHEMICAL | 1 |
| de | PERSON | 1 |
| deluca john meza cecilia | PERSON | 1 |
| deaths | DISEASE | 1 |
| decavèle maxens gatulle nicolas | PERSON | 1 |
| defining severe community | ORG | 1 |
| delémont | CHEMICAL | 1 |
| demyelinating polyneuropathy | DISEASE | 1 |
| demyelinating encephalopathy | DISEASE | 1 |
| depressive | DISEASE | 1 |
| determination of csf | ORG | 1 |
| detroit | GPE | 1 |
| dex csdh | PERSON | 1 |
| di | CHEMICAL | 1 |
| di carlo davide | CHEMICAL | 1 |
| diagnostic | GPE | 1 |
| digital | ORG | 1 |
| ditan | CHEMICAL | 1 |
| ditan hospital | LOC | 1 |
| donatella | CHEMICAL | 1 |
| daps | CHEMICAL | 1 |
| d drenkard and n gropp | ORG | 1 |
| d dimer | PERSON | 1 |
| coronavirus infection | DISEASE | 1 |
| comité | CHEMICAL | 1 |
| comité de protection des personnes sud est ii | ORG | 1 |
| compendium | PERSON | 1 |
| comprehensive | ORG | 1 |
| condition | ORG | 1 |
| conductance | PERSON | 1 |
| confirmed cas | ORG | 1 |
| control of sars cov | ORG | 1 |
| cornblath 4 | ORG | 1 |
| cornblath 4 respiratory tract or gastrointestinal infections | CHEMICAL | 1 |
| coronaviridae | ORG | 1 |
| coronavirus disease 2019 covid 19 | ORG | 1 |
| coronavirus death | DISEASE | 1 |
| coronavirus infections | DISEASE | 1 |
| d d c | CHEMICAL | 1 |
| coronaviruses | TAXON | 1 |
| couratier c joguet g | CHEMICAL | 1 |
| coutinho | PERSON | 1 |
| covid 19 autoimmune | ORG | 1 |
| covid 19 autoimmune haemolytic anaemia | DISEASE | 1 |
| covid 19 coagulopathy | ORG | 1 |
| cox proportional hazard | TAXON | 1 |
| critical care lucca study investigators | ORG | 1 |
| critically ill | DISEASE | 1 |
| célia | CHEMICAL | 1 |
| d 20 e g brain | CHEMICAL | 1 |
| d aleo michele giannini ottavio | CHEMICAL | 1 |
| d aliberti giuseppe title spinal | CHEMICAL | 1 |
| donatella de massis patrizia | PERSON | 1 |
| douplat | CHEMICAL | 1 |
| dr a barbour university of texas san antonio usa | ORG | 1 |
| fan m et al | PERSON | 1 |
| epstein barr viral infection | DISEASE | 1 |
| ethical | PERSON | 1 |
| euroqol 5d eq | ORG | 1 |
| europe north america | LOC | 1 |
| europe participants | LOC | 1 |
| excess | ORG | 1 |
| facs | ORG | 1 |
| fda | ORG | 1 |
| fh | DISEASE | 1 |
| flair fluid | ORG | 1 |
| frg | ORG | 1 |
| fz | ORG | 1 |
| facial diplegia | DISEASE | 1 |
| fasano | ORG | 1 |
| epstein bar | PERSON | 1 |
| feinstein | PERSON | 1 |
| ferini strambi luigi | PERSON | 1 |
| ferreira | CHEMICAL | 1 |
| ferrero | PERSON | 1 |
| fig 1 | PERSON | 1 |
| fig 3 association | ORG | 1 |
| fishers | PERSON | 1 |
| flaccid myelitis | PERSON | 1 |
| florida | GPE | 1 |
| fluid attenuated inversion recovery flair | ORG | 1 |
| foldax | ORG | 1 |
| fondazione italiana | ORG | 1 |
| fondazione italiana sclerosi multiplav giampaolo brichetto | CHEMICAL | 1 |
| epstein bar virus cmv hiv 1 borrelia | DISEASE | 1 |
| episodic | ORG | 1 |
| dr r ackermann | CHEMICAL | 1 |
| eu | ORG | 1 |
| dr r ackermann department of neurology university of cologne frg | ORG | 1 |
| dresden klinikum | PERSON | 1 |
| du | ORG | 1 |
| due | ORG | 1 |
| dynamed | PERSON | 1 |
| e emmer b j roos y b w e | CHEMICAL | 1 |
| ecass ii | CHEMICAL | 1 |
| edss ms | LOC | 1 |
| eeg evoked potentials ep electroneurographic | ORG | 1 |
| elisa | ORG | 1 |
| eme | CHEMICAL | 1 |
| ep | CHEMICAL | 1 |
| escmid emerging infections task force 2020 | ORG | 1 |
| eaton lambert | ORG | 1 |
| epidemic | DISEASE | 1 |
| editorial board | ORG | 1 |
| egger | PERSON | 1 |
| elblandklinikum meißen | PERSON | 1 |
| electric healthcare | ORG | 1 |
| electroencephalogram | PERSON | 1 |
| electromyographic recordings eng emg | ORG | 1 |
| elisa montanaro elisa | PERSON | 1 |
| elitech | CHEMICAL | 1 |
| elitech group ab | ORG | 1 |
| emergency department | ORG | 1 |
| emergency departments | PERSON | 1 |
| emergency medical dispatch | ORG | 1 |
| encephalopathy | DISEASE | 1 |
| vzv cmv ebv syphilis | DISEASE | 1 |
| dizz delirium | CHEMICAL | 1 |
| vaccine injury | DISEASE | 1 |
| nerve pain | DISEASE | 1 |
| neuromyelitis optica spectrum disorder | DISEASE | 1 |
| neuromyelitis optica spectrum disorders guillain | DISEASE | 1 |
| neuron | ORG | 1 |
| neuronal damage | DISEASE | 1 |
| neuronal degeneration | DISEASE | 1 |
| neuronal dysfunction | DISEASE | 1 |
| neuronal injury | DISEASE | 1 |
| neuronal loss | DISEASE | 1 |
| neuropathies | DISEASE | 1 |
| neuropsychiatric comorbidities | DISEASE | 1 |
| neuropsychiatric complications | DISEASE | 1 |
| neuropsychiatric manifestations | DISEASE | 1 |
| neuropsychiatric symptomatology | DISEASE | 1 |
| neurosyphilis | GPE | 1 |
| neutrophil | GPE | 1 |
| nonconvulsive status epilepticus ncse | DISEASE | 1 |
| nose sars | DISEASE | 1 |
| nosocomial superinfections | DISEASE | 1 |
| nucleotide | CHEMICAL | 1 |
| numbness | DISEASE | 1 |
| nutritional deficiencies infectious autoimmune diseases lupus sjogren s vasculitis | DISEASE | 1 |
| obstructive pulmonary disease obesity | DISEASE | 1 |
| occipital infarction | DISEASE | 1 |
| olfactory and gustatory dysfunction | DISEASE | 1 |
| olfactory disorders | DISEASE | 1 |
| olfactory identification deficits | DISEASE | 1 |
| olfactory loss | DISEASE | 1 |
| oligoarthritis | DISEASE | 1 |
| onconeural | TAXON | 1 |
| neuromuscular junction disorder | DISEASE | 1 |
| neuromuscular disorders nmds | DISEASE | 1 |
| neuromuscular blockade | DISEASE | 1 |
| neurological damage | DISEASE | 1 |
| neural damage | DISEASE | 1 |
| neurocognitive deficits | DISEASE | 1 |
| neurocognitive impairments | DISEASE | 1 |
| neurodegenerative disease | DISEASE | 1 |
| neurodegenerative disorders | DISEASE | 1 |
| neurodegenerative or neuroimmunological diseases | DISEASE | 1 |
| neuroimmunological disorders interferon beta 1b | DISEASE | 1 |
| neuroinvasive viruses | TAXON | 1 |
| neurologic complication | DISEASE | 1 |
| neurologic deficits | DISEASE | 1 |
| neurological and cognitive status | DISEASE | 1 |
| neurological and psychiatric | DISEASE | 1 |
| neurological complications neurologic manifestations | DISEASE | 1 |
| neurological death | DISEASE | 1 |
| neurological syndromes | DISEASE | 1 |
| neurological deficit | DISEASE | 1 |
| neurological deficit left middle cerebral artery syndrome | DISEASE | 1 |
| neurological diseases cerebrovascular diseases | DISEASE | 1 |
| neurological diseases p 0 001 | DISEASE | 1 |
| neurological disorder | DISEASE | 1 |
| neurological disorders neurological manifestations | DISEASE | 1 |
| neurological disturbances | DISEASE | 1 |
| neurological illness 218 1 2 | DISEASE | 1 |
| neurological illness hemorrhagic | DISEASE | 1 |
| neurological manifestation | DISEASE | 1 |
| neurological manifestations disease | DISEASE | 1 |
| neurological problems | DISEASE | 1 |
| neurological psychiatric cognitive | DISEASE | 1 |
| onconeural antibodies | TAXON | 1 |
| opacities | DISEASE | 1 |
| opportunistic | TAXON | 1 |
| poststroke dysphagia | DISEASE | 1 |
| phosphate | CHEMICAL | 1 |
| physical disability | DISEASE | 1 |
| pigs | TAXON | 1 |
| pipeline | CHEMICAL | 1 |
| plasmacytic transformation | DISEASE | 1 |
| platelet and clotting cascade | DISEASE | 1 |
| platelet dysfunction | DISEASE | 1 |
| pleural effusions | DISEASE | 1 |
| plexopathies and peripheral polyneuropathies a | DISEASE | 1 |
| pneumonitis | DISEASE | 1 |
| polyneuropathy encephalitis | DISEASE | 1 |
| polyradiculopathy | DISEASE | 1 |
| posterior leukoencephalopathy syndrome | DISEASE | 1 |
| postviral olfactory dysfunction | DISEASE | 1 |
| peripheral polyneuropathies | DISEASE | 1 |
| potassium | CHEMICAL | 1 |
| prednisolone | CHEMICAL | 1 |
| prednisone | CHEMICAL | 1 |
| primary abscess | DISEASE | 1 |
| procalcitonin | CHEMICAL | 1 |
| psychiatric symptoms stress anxiety | DISEASE | 1 |
| psychological distress | DISEASE | 1 |
| psychoneuroimmunity | DISEASE | 1 |
| psychoses | DISEASE | 1 |
| pulmonary and inflammatory complications | DISEASE | 1 |
| pulmonary complications | DISEASE | 1 |
| pulmonary damage | DISEASE | 1 |
| pulmonary edema | DISEASE | 1 |
| peripheral vestibular disorder | DISEASE | 1 |
| peripheral neuropathies | DISEASE | 1 |
| optica spectrum | PERSON | 1 |
| panencephalitis | DISEASE | 1 |
| organ dysfunction failure | DISEASE | 1 |
| organ infection | DISEASE | 1 |
| organism | TAXON | 1 |
| orthostatic | DISEASE | 1 |
| orthostatic dysregulation | DISEASE | 1 |
| osteoarticular | DISEASE | 1 |
| overload | DISEASE | 1 |
| oxford centre | PERSON | 1 |
| pain agitation | DISEASE | 1 |
| pandemic acute respiratory syndrome | DISEASE | 1 |
| pandemic parkinson s disease | DISEASE | 1 |
| pandemic depression anxiety | DISEASE | 1 |
| pandemic disease | DISEASE | 1 |
| pangolins | TAXON | 1 |
| peripheral nervous system manifestations | DISEASE | 1 |
| pantoprazole rosuvastatin | PERSON | 1 |
| paraneoplastic autoimmune | DISEASE | 1 |
| paraplegia | DISEASE | 1 |
| paresis | DISEASE | 1 |
| paresthesias | DISEASE | 1 |
| parkinson s disease | DISEASE | 1 |
| pathologies aneurysmal subarachnoid haemorrhage | DISEASE | 1 |
| pericardial effusion | DISEASE | 1 |
| peripheral demyelination | DISEASE | 1 |
| peripheral disorders | DISEASE | 1 |
| peripheral edema | DISEASE | 1 |
| peripheral hypogeusia hyposmia | DISEASE | 1 |
| peripheral nervous system diseases | DISEASE | 1 |
| nervous system injury | DISEASE | 1 |
| neoplastic diseases p 0 001 | DISEASE | 1 |
| pulmonary embolism | DISEASE | 1 |
| neoplasms | DISEASE | 1 |
| inflammatory syndromes | DISEASE | 1 |
| influenza | ORG | 1 |
| influenza m2 ion channel | ORG | 1 |
| inter national collaborations | ORG | 1 |
| interferon ifn | CHEMICAL | 1 |
| interferon beta ifn β | CHEMICAL | 1 |
| intraarterial thrombi | DISEASE | 1 |
| intracerebral haemorrhage | DISEASE | 1 |
| intracerebral hemorrhage aneurysmal subarachnoid hemorrhage | DISEASE | 1 |
| intracerebral hemorrhages ich | DISEASE | 1 |
| intracranial aneurysms | DISEASE | 1 |
| intrathoracic | GPE | 1 |
| intravascular coagulopathy | DISEASE | 1 |
| irbesartan hydrochlorothiazide acetylsalicylic | ORG | 1 |
| irbesartan hydrochlorothiazide acetylsalicylic acid pantoprazole rosuvastatin allopurinol | CHEMICAL | 1 |
| ischaemia | DISEASE | 1 |
| ischaemic | DISEASE | 1 |
| ischaemic strokes | DISEASE | 1 |
| ischemic attacks 1 cerebral venous thrombosis | DISEASE | 1 |
| ischemic lesions | DISEASE | 1 |
| j3akzx10 | CHEMICAL | 1 |
| la misura | ORG | 1 |
| lacunar stroke | DISEASE | 1 |
| laninamivir | CHEMICAL | 1 |
| left hemiplegia hypoesthesia | DISEASE | 1 |
| left sensorimotor hemiparesis | DISEASE | 1 |
| limbic encephalitis | DISEASE | 1 |
| liquide cephalorachidien | CHEMICAL | 1 |
| liver disease | DISEASE | 1 |
| inflammatory injury of the endothelium | DISEASE | 1 |
| inflammatory demyelinating polyradiculoneuropathy | DISEASE | 1 |
| inflammatory demyelinating polyneuropathy | DISEASE | 1 |
| impaired muscle | DISEASE | 1 |
| hypodensity | DISEASE | 1 |
| hypoesthesia | DISEASE | 1 |
| hypointensity | DISEASE | 1 |
| hypopsia myalgia | DISEASE | 1 |
| hyposmia anosmia | DISEASE | 1 |
| hyposmia muscle damage | DISEASE | 1 |
| hypothyroidism myasthenia gravis | DISEASE | 1 |
| hypotrophy | DISEASE | 1 |
| hypoventilation syndrome | DISEASE | 1 |
| hypoxemia | DISEASE | 1 |
| hématologie grrr | CHEMICAL | 1 |
| impaired consciousness acute cerebrovascular disease ataxia | DISEASE | 1 |
| impaired demented | DISEASE | 1 |
| impairment of consciousness | DISEASE | 1 |
| infectious symptoms | DISEASE | 1 |
| impairment the neurological symptoms | DISEASE | 1 |
| inactivity and stress neuromuscular disease covid | DISEASE | 1 |
| infarction | DISEASE | 1 |
| infarctions | DISEASE | 1 |
| infection cerebral venous sinus thrombosis | DISEASE | 1 |
| infection coronavirus disease | DISEASE | 1 |
| infection nosocomial infections | DISEASE | 1 |
| infection pd | DISEASE | 1 |
| infection sepsis | DISEASE | 1 |
| infectious agents | DISEASE | 1 |
| infectious and pulmonary complications | DISEASE | 1 |
| infectious demyelination | DISEASE | 1 |
| infectious myelitis | DISEASE | 1 |
| loneliness | DISEASE | 1 |
| loss of fine hair like endings of the olfactory | DISEASE | 1 |
| loss of myelin c | DISEASE | 1 |
| muscle symptoms | DISEASE | 1 |
| multiorgan failure | DISEASE | 1 |
| multiple sclerosis a multi | DISEASE | 1 |
| multiple sclerosis acute | DISEASE | 1 |
| multiple sclerosis covid | DISEASE | 1 |
| multiple sclerosis neuropsychiatric | DISEASE | 1 |
| multiple sclerosis disease | DISEASE | 1 |
| mumps virus | TAXON | 1 |
| mural hematoma | DISEASE | 1 |
| murine | TAXON | 1 |
| muscle breakdown | DISEASE | 1 |
| muscle denervation | DISEASE | 1 |
| muscle diseases | DISEASE | 1 |
| muscle mass insomnia | DISEASE | 1 |
| muscular atrophy | DISEASE | 1 |
| multiorgan | GPE | 1 |
| muscular damage | DISEASE | 1 |
| muscular injury symptoms | DISEASE | 1 |
| myalgia muscular pain | DISEASE | 1 |
| myelin cross | ORG | 1 |
| myelopathy | DISEASE | 1 |
| myocarditis | DISEASE | 1 |
| myopathy | DISEASE | 1 |
| myositis | DISEASE | 1 |
| ncov cov 2 | ORG | 1 |
| ncov investigation team et al | ORG | 1 |
| nan neurological | ORG | 1 |
| nasopharyngeal and uterine cancer | DISEASE | 1 |
| neck pain | DISEASE | 1 |
| multiorgan damage | DISEASE | 1 |
| multi organ failure | DISEASE | 1 |
| loss of smell and taste | DISEASE | 1 |
| memory deficits | DISEASE | 1 |
| low cognitive function | DISEASE | 1 |
| lower extremities sensory changes weakness | DISEASE | 1 |
| lung abnormalities | DISEASE | 1 |
| lung disease | DISEASE | 1 |
| lung heart kidney intestine | DISEASE | 1 |
| lung injury | DISEASE | 1 |
| lymphomas | DISEASE | 1 |
| lymphomeningoradiculitis bannwarth s syndrome | DISEASE | 1 |
| malaise muscle ache cough fever | DISEASE | 1 |
| malignancies | DISEASE | 1 |
| malignant gliomas | DISEASE | 1 |
| malignant ischemic stroke | DISEASE | 1 |
| medicare registry urgent | ORG | 1 |
| meningeal irritation | DISEASE | 1 |
| mouse | TAXON | 1 |
| meningeal signs b | DISEASE | 1 |
| meningitis neurosyphilis subacute | DISEASE | 1 |
| metabolic derangements toxemia | DISEASE | 1 |
| metabolic encephalopathy | DISEASE | 1 |
| metabolic encephalopathy headache myalgia | DISEASE | 1 |
| metabolic encephalopathy headache myalgia myelitis ataxia | DISEASE | 1 |
| methicillin | CHEMICAL | 1 |
| microcirculation impairment | DISEASE | 1 |
| micturate | CHEMICAL | 1 |
| monosymptomatic | DISEASE | 1 |
| motor demyelinating polyradiculoneuropathy | DISEASE | 1 |
| motor neuron disease | DISEASE | 1 |
| motor weakness | DISEASE | 1 |
| pulmonary edema congestive hepatopathy | DISEASE | 1 |
| pulmonary infections | DISEASE | 1 |
| valente mariarosaria | PERSON | 1 |
| the hospital universitario infanta leonor | ORG | 1 |
| the uk ms society | ORG | 1 |
| the uke covid 19 study group | ORG | 1 |
| the united kingdom | GPE | 1 |
| the united kingdom figure | GPE | 1 |
| the united kingdom global neurotrauma research g | ORG | 1 |
| the united states acute | GPE | 1 |
| the united states of america | GPE | 1 |
| the university of palermo | ORG | 1 |
| the university of pennsylvania smell identification test outcome | ORG | 1 |
| the university of utah institutional review board guidelines | ORG | 1 |
| the vaccine injury compensation program | ORG | 1 |
| the washington state 2019 | ORG | 1 |
| the world health organization 1 neurological | ORG | 1 |
| the world health organization who | ORG | 1 |
| the appropriate ethics committee | ORG | 1 |
| the associated discomfort individuals | ORG | 1 |
| the association of loss of smell | ORG | 1 |
| the authors ethical | ORG | 1 |
| the epidemiology research council | ORG | 1 |
| the ethical review board of each hospital | ORG | 1 |
| the institutional review board | ORG | 1 |
| the national reference center for high grade | ORG | 1 |
| this boutoleau bretonniere et al | PERSON | 1 |
| thoracic sea | LOC | 1 |
| thoracic whereas classic | ORG | 1 |
| throat swab | PERSON | 1 |
| thromboembolic disease | DISEASE | 1 |
| thromboembolic diseases | DISEASE | 1 |
| thromboembolism | DISEASE | 1 |
| the u s centers for disease control and prevention 11 immunosuppression | ORG | 1 |
| the sequential organ failure assessment sofa | ORG | 1 |
| the sea | LOC | 1 |
| the mrc national survey of health and development cohort | ORG | 1 |
| the indian academy of neurology association | ORG | 1 |
| the infanta leonor thrombosis research group | ORG | 1 |
| the institutional review board of university of udine medical school population | ORG | 1 |
| the international committee on taxonomy of viruses 2020 | ORG | 1 |
| the international physical activity questionnaire short form | ORG | 1 |
| the international subarachnoid aneurysm trial | ORG | 1 |
| the italian multiple sclerosis foundation fism | ORG | 1 |
| the italian neurological society | ORG | 1 |
| the jbi critical appraisal tool | ORG | 1 |
| the karnofsky performance status scale 24 | ORG | 1 |
| the lean european open survey | ORG | 1 |
| the lyon stroke center network | ORG | 1 |
| the mistie 3 minimially invasive surgery with thrombolysis | ORG | 1 |
| the ms society of canada grant egid3185 | ORG | 1 |
| the sars cov 2 epidemic | ORG | 1 |
| the massachusetts general hospital s institutional review board a | ORG | 1 |
| the medical research council | ORG | 1 |
| the multiple sclerosis impact scale | ORG | 1 |
| the multiple sclerosis study group | ORG | 1 |
| the national institute for health research university | ORG | 1 |
| the national institutes of health stroke scale | ORG | 1 |
| the national research ethics service committee | ORG | 1 |
| the neuromuscular clinic | ORG | 1 |
| the new york presbyterian hospital treating | ORG | 1 |
| the oxford centre for evidence based | ORG | 1 |
| the partners healthcare institutional review board | ORG | 1 |
| the people s republic of china diagnosis | GPE | 1 |
| the randolf klingebiel | ORG | 1 |
| thrombolysis | DISEASE | 1 |
| thrombophilia | DISEASE | 1 |
| thromboplastin time n | PERSON | 1 |
| viremia seizures | DISEASE | 1 |
| ventilation liver failure | DISEASE | 1 |
| ventilator dependency | DISEASE | 1 |
| vertebral artery dissection | DISEASE | 1 |
| vessel disease | DISEASE | 1 |
| vessel disease ce cardioembolic | DISEASE | 1 |
| vessel disease stroke | DISEASE | 1 |
| vessel occlusion multi | DISEASE | 1 |
| viral diseases | DISEASE | 1 |
| viral encephalitis 1 | TAXON | 1 |
| viral illness | DISEASE | 1 |
| viral infiltration peripheral hypercytokinaemia | DISEASE | 1 |
| viral loss of smell | DISEASE | 1 |
| viremia | DISEASE | 1 |
| virus cmv hiv 1 | TAXON | 1 |
| vascular wall inflammation | DISEASE | 1 |
| virus facial diplegia | DISEASE | 1 |
| virus hev | TAXON | 1 |
| virus jhm immunoglobulin | TAXON | 1 |
| virus infection | DISEASE | 1 |
| virus infections | DISEASE | 1 |
| vomiting | DISEASE | 1 |
| white matter lesion segmentation odor | DISEASE | 1 |
| white matter lesions | DISEASE | 1 |
| white matter perilesional edema | DISEASE | 1 |
| zoster virus antibodies | TAXON | 1 |
| β amyloid deposition | PERSON | 1 |
| β burden | PERSON | 1 |
| β2 | ORG | 1 |
| venous thromboembolism ischemic stroke | DISEASE | 1 |
| vascular stenosis | DISEASE | 1 |
| thrombotic disorders | DISEASE | 1 |
| trigeminal neuralgia | DISEASE | 1 |
| thrombotic microangiopathy | DISEASE | 1 |
| thrombotic microangiopathy tma | DISEASE | 1 |
| thyroxin | CHEMICAL | 1 |
| tick bite | DISEASE | 1 |
| tissue injury | DISEASE | 1 |
| tocilizumab | CHEMICAL | 1 |
| togroin | CHEMICAL | 1 |
| tonic clonic seizure | DISEASE | 1 |
| toxoplasmosis | DISEASE | 1 |
| traumatic head injury | DISEASE | 1 |
| traumatic intracranial hypertension | DISEASE | 1 |
| traumatic stress disorder | DISEASE | 1 |
| traumatic stress disorder panic attacks anxiety | DISEASE | 1 |
| tuberculosis | DISEASE | 1 |
| vascular malformation | DISEASE | 1 |
| tuberculous meningitis | DISEASE | 1 |
| tumor necrosis | DISEASE | 1 |
| tumour | DISEASE | 1 |
| turbidimetric d dimer | PERSON | 1 |
| type 2 diabetes | DISEASE | 1 |
| type 2 respiratory failure | DISEASE | 1 |
| uk cash d cash | CHEMICAL | 1 |
| unruptured aneurysms | DISEASE | 1 |
| unruptured cerebral aneurysms | DISEASE | 1 |
| upper motor neuron disorder | DISEASE | 1 |
| valsartan | CHEMICAL | 1 |
| vascular dementia migraine | DISEASE | 1 |
| vascular disease | DISEASE | 1 |
| the hyperacute stroke unit | ORG | 1 |
| the hospital anxiety and depression scale | ORG | 1 |
| pulmonary lesion | DISEASE | 1 |
| the health technology assessment hta programme | ORG | 1 |
| ruptures | DISEASE | 1 |
| s mouth | DISEASE | 1 |
| sich | DISEASE | 1 |
| secondary haemorrhage | DISEASE | 1 |
| sedentarism | DISEASE | 1 |
| seizures cancer disease | DISEASE | 1 |
| seizures sars cov | DISEASE | 1 |
| sensorium | DISEASE | 1 |
| sensory deficits | DISEASE | 1 |
| sepsis liver failure | DISEASE | 1 |
| sepsis preeclampsia | DISEASE | 1 |
| septic pres | DISEASE | 1 |
| septic shock | DISEASE | 1 |
| sha 717b69885ef54ac00216d998646fb04936ab51a9 | CHEMICAL | 1 |
| sham | PERSON | 1 |
| sinus thrombosis | DISEASE | 1 |
| skeletal muscle a | DISEASE | 1 |
| skeletal muscle damage | DISEASE | 1 |
| skin rash erythema | DISEASE | 1 |
| smell and taste disorders | DISEASE | 1 |
| smell impairment | DISEASE | 1 |
| smell stroke | DISEASE | 1 |
| social behaviors | DISEASE | 1 |
| sodium acetate | CHEMICAL | 1 |
| sodium potassium | CHEMICAL | 1 |
| sorbitol | CHEMICAL | 1 |
| spastic | DISEASE | 1 |
| spastic paraparesis | DISEASE | 1 |
| spastic paraparesis babinski | DISEASE | 1 |
| ruptured intracranial aneurysms | DISEASE | 1 |
| ruptured | DISEASE | 1 |
| runny nose | DISEASE | 1 |
| respiratory insufficiency | DISEASE | 1 |
| pulmonary vulnerability | DISEASE | 1 |
| qsars cov | CHEMICAL | 1 |
| quadriplegic | DISEASE | 1 |
| rabbit antihuman | TAXON | 1 |
| radiculopathy | DISEASE | 1 |
| ramipril | CHEMICAL | 1 |
| rat | TAXON | 1 |
| reduction of vascular diameter | DISEASE | 1 |
| respiratory complaints | DISEASE | 1 |
| respiratory deterioration | DISEASE | 1 |
| respiratory failure myelitis ataxia | DISEASE | 1 |
| respiratory failure stroke | DISEASE | 1 |
| respiratory impairment neurological symptoms | DISEASE | 1 |
| respiratory or gastrointestinal gi symptoms | DISEASE | 1 |
| rivaroxaban | CHEMICAL | 1 |
| respiratory or gastrointestinal symptoms | DISEASE | 1 |
| respiratory syndrome mers coronavirus | DISEASE | 1 |
| respiratory syndrome viral diseases | DISEASE | 1 |
| respiratory syndrome corona virus mers cov neurological complications | DISEASE | 1 |
| respiratory syndrome coronavirus mers cov sars | DISEASE | 1 |
| respiratory syndrome coronavirus sars cov pulmonary disorder | DISEASE | 1 |
| respiratory syndrome coronavirus sars cov pulmonary infection | DISEASE | 1 |
| respiratory syndrome coronavirus causes multiple organ damage | DISEASE | 1 |
| respiratory syndrome coronavirus disease | DISEASE | 1 |
| respiratory tract infection | DISEASE | 1 |
| respiratory virus infections | DISEASE | 1 |
| rhinorrhea or nasal obstruction a multi | DISEASE | 1 |
| rigidity | DISEASE | 1 |
| sphincter incontinence | DISEASE | 1 |
| sphingosine | CHEMICAL | 1 |
| spinal infection | DISEASE | 1 |
| the centers for disease control and prevention | ORG | 1 |
| thank d | CHEMICAL | 1 |
| the alberta stroke program early ct score aspects | ORG | 1 |
| the american academy of neurology | ORG | 1 |
| the american thoracic society | ORG | 1 |
| the angiotensin converting enzyme 2 | ORG | 1 |
| the beltran corbellini et al | PERSON | 1 |
| the covid | ORG | 1 |
| the covid impact interview | ORG | 1 |
| the crui care agreement | ORG | 1 |
| the csf sars cov 2 rt pcr | ORG | 1 |
| the canadian network | ORG | 1 |
| the cardiovascular health study guillain barré | ORG | 1 |
| the centers for disease control conflicts | ORG | 1 |
| the charlson comorbidity index | ORG | 1 |
| temporal hypodensity | DISEASE | 1 |
| the chinese clinical guidance for covid 19 pneumonia diagnosis and treatment | ORG | 1 |
| the diagnosis and treatment of covid | ORG | 1 |
| the diagnosis and treatment of covid 19 | ORG | 1 |
| the editorial boards of multiple sclerosis journal | ORG | 1 |
| the efficacy and evaluation eme programme a medical neurologic | ORG | 1 |
| the emergency department | ORG | 1 |
| the emergency department ed | ORG | 1 |
| the european cooperative acute stroke study | ORG | 1 |
| the european cooperative acute stroke study ecass ii | ORG | 1 |
| the european society | ORG | 1 |
| the french intensive care society | ORG | 1 |
| the french rare health care for neuromuscular diseases network management | ORG | 1 |
| the glasgow coma scale | ORG | 1 |
| tenofovir | CHEMICAL | 1 |
| temporal dispersion | DISEASE | 1 |
| spirochetal | TAXON | 1 |
| strumento | CHEMICAL | 1 |
| status comorbidities | DISEASE | 1 |
| status fever | DISEASE | 1 |
| status focal neurological signs | DISEASE | 1 |
| status ischemic stroke | DISEASE | 1 |
| status neurodegeneration | DISEASE | 1 |
| status seizures | DISEASE | 1 |
| stress anxiety depression | DISEASE | 1 |
| stress helplessness | DISEASE | 1 |
| stroke covid | DISEASE | 1 |
| stroke hypertension | DISEASE | 1 |
| stroke lupus | DISEASE | 1 |
| stroke cerebrovascular accident | DISEASE | 1 |
| strokes confusional | DISEASE | 1 |
| subarachnoid aneurysm | DISEASE | 1 |
| taste disorders | DISEASE | 1 |
| subarachnoid haemorrhage | DISEASE | 1 |
| subarachnoid haemorrhage sah | DISEASE | 1 |
| subarachnoid hemorrhage | DISEASE | 1 |
| subarachnoid hemorrhage sah | DISEASE | 1 |
| subdural hematoma | DISEASE | 1 |
| sugars | CHEMICAL | 1 |
| supratentorial lobar | DISEASE | 1 |
| swab test | ORG | 1 |
| swallowing dysfunction | DISEASE | 1 |
| swelling | DISEASE | 1 |
| swine | TAXON | 1 |
| tachyarrhythmia | DISEASE | 1 |
| tachycardia | DISEASE | 1 |
| hypertensive ich | DISEASE | 1 |
| hypertension renal failure | DISEASE | 1 |
| hypertension hyperlipidemia hypothyroidism | DISEASE | 1 |
| angiotensin i | CHEMICAL | 1 |
| autoimmune gbs | DISEASE | 1 |
| autoimmune aggression | DISEASE | 1 |
| autoimmune complications | DISEASE | 1 |
| autoimmune disorders | DISEASE | 1 |
| autoimmune encephalitic syndromes | DISEASE | 1 |
| autoimmune encephalopathy | DISEASE | 1 |
| autoimmune hemolytic anemia | DISEASE | 1 |
| autoimmune meningoencephalitis | DISEASE | 1 |
| autoimmune neoplastic or neurologic antecedences | DISEASE | 1 |
| autoimmune neuropathy | DISEASE | 1 |
| autoimmune phenomenon | DISEASE | 1 |
| autoimmunity guillain | DISEASE | 1 |
| autonomic failure | DISEASE | 1 |
| axonal affection | DISEASE | 1 |
| axonal demyelinating | DISEASE | 1 |
| axonal motor damage | DISEASE | 1 |
| axonal or demyelinating polyradiculoneuropathy | DISEASE | 1 |
| axonal sensorimotor polyneuropathy | DISEASE | 1 |
| bacilli | CHEMICAL | 1 |
| back pain | DISEASE | 1 |
| bacterial colonization | DISEASE | 1 |
| bacterial infection | DISEASE | 1 |
| bacterial infections | DISEASE | 1 |
| bat | TAXON | 1 |
| bats | TAXON | 1 |
| betacoronoviride | CHEMICAL | 1 |
| bilirubin | CHEMICAL | 1 |
| bisoprolol | CHEMICAL | 1 |
| bladder dysfunction | DISEASE | 1 |
| atherosclerotic cardioembolic | DISEASE | 1 |
| ataxia | DISEASE | 1 |
| astrocytomas | DISEASE | 1 |
| aortic arch thrombus | DISEASE | 1 |
| angiotensinconverting enzyme 2 ace 2 receptor | CHEMICAL | 1 |
| anomia | DISEASE | 1 |
| anosmia ageusia | ORG | 1 |
| anosmia ageusia central respiratory | ORG | 1 |
| anosmia ageusia stroke aidp | ORG | 1 |
| anosmia ageusia stroke aidp acute necrotizing hemorrhagic encephalopathy | DISEASE | 1 |
| anosmia dysgeusia dysarthria | DISEASE | 1 |
| anosmia encephalopathy | DISEASE | 1 |
| anosmia hyposmia | DISEASE | 1 |
| anticardiolipin | DISEASE | 1 |
| anticytokine | CHEMICAL | 1 |
| antiplatelets | CHEMICAL | 1 |
| anxiety disorder depressive symptoms | DISEASE | 1 |
| aortic ischemic stroke | DISEASE | 1 |
| astrocytoma | DISEASE | 1 |
| apixaban | CHEMICAL | 1 |
| appendix | GPE | 1 |
| areflexia | DISEASE | 1 |
| areflexic | DISEASE | 1 |
| areflexic tetraplegia | DISEASE | 1 |
| aripiprazole | CHEMICAL | 1 |
| artery atherosclerotic infarction | DISEASE | 1 |
| artery infarctions | DISEASE | 1 |
| artery ischemic stroke | DISEASE | 1 |
| artery ischemic strokes | DISEASE | 1 |
| artery occlusion | DISEASE | 1 |
| arthralgia | DISEASE | 1 |
| ascites | DISEASE | 1 |
| bladder retention neurological | DISEASE | 1 |
| blood coagulability | DISEASE | 1 |
| blood coagulation | DISEASE | 1 |
| cerebral venous thrombosis | DISEASE | 1 |
| cellulitis | DISEASE | 1 |
| cereb headache hyposmia | DISEASE | 1 |
| cerebral alzheimer s disease | DISEASE | 1 |
| cerebral air embolism | DISEASE | 1 |
| cerebral aneurysm | DISEASE | 1 |
| cerebral atrophy | DISEASE | 1 |
| cerebral infarct | DISEASE | 1 |
| cerebral infarction | DISEASE | 1 |
| cerebral infarcts | DISEASE | 1 |
| cerebral vasoconstriction syndrome | DISEASE | 1 |
| cerebral vein thrombosis | DISEASE | 1 |
| cerebral vein thrombosis cvt | DISEASE | 1 |
| cerebral venous sinus thrombosis | DISEASE | 1 |
| cerebral β amyloid deposition | DISEASE | 1 |
| carotid artery thrombosis | DISEASE | 1 |
| cerebral β amyloid status | DISEASE | 1 |
| cerebrovascular or cerebral vein thrombosis | DISEASE | 1 |
| cerebrovascular accident | DISEASE | 1 |
| cerebrovascular accidents | DISEASE | 1 |
| cerebrovascular complications | DISEASE | 1 |
| cerebrovascular death | DISEASE | 1 |
| cerebrovascular disease ataxia | DISEASE | 1 |
| cerebrovascular diseases cvd | DISEASE | 1 |
| cerebrovascular endothelial dysfunction | DISEASE | 1 |
| cerebrovascular or cardiovascular disease | DISEASE | 1 |
| cervical and thoracic locations | DISEASE | 1 |
| cervical artery dissection | DISEASE | 1 |
| cervicothoracic | GPE | 1 |
| catecholamines | CHEMICAL | 1 |
| carotid artery dissection | DISEASE | 1 |
| blood urea nitrogen | CHEMICAL | 1 |
| cardiac arrest encephalopathy | DISEASE | 1 |
| blurred vision | DISEASE | 1 |
| blurred vision pres | DISEASE | 1 |
| bovine | CHEMICAL | 1 |
| brain edema | DISEASE | 1 |
| brain injury | DISEASE | 1 |
| brain pathologies | DISEASE | 1 |
| brain tumours | DISEASE | 1 |
| breast carcinoma | DISEASE | 1 |
| breath diarrhea | DISEASE | 1 |
| bulbar infections | DISEASE | 1 |
| burgdorferi strain m34 | DISEASE | 1 |
| capsulo lenticular lesion | DISEASE | 1 |
| carbohydrates | CHEMICAL | 1 |
| cardiac arrhythmia | DISEASE | 1 |
| cardiovascular pathologies | DISEASE | 1 |
| cardiac arrhythmias | DISEASE | 1 |
| cardiac death | DISEASE | 1 |
| cardiac disease | DISEASE | 1 |
| cardiac failure | DISEASE | 1 |
| cardiac peripheral vascular disease | DISEASE | 1 |
| cardio respiratory failure | DISEASE | 1 |
| cardioembolic stroke atrial fibrillation | DISEASE | 1 |
| cardiomyopathy | DISEASE | 1 |
| cardiovascular and pulmonary diseases diabetes | DISEASE | 1 |
| cardiovascular comorbidities | DISEASE | 1 |
| cardiovascular disease diabetes | DISEASE | 1 |
| cardiovascular metabolic diseases | DISEASE | 1 |
| cardiovascular morbidity | DISEASE | 1 |
| angiotensin converting | PERSON | 1 |
| angiotensin 1 9 sars cov 2 cell | CHEMICAL | 1 |
| hypertension hyperlipidemia diabetes mellitus | DISEASE | 1 |
| aneurysms | DISEASE | 1 |
| wong michael newton judith | PERSON | 1 |
| woo marcel | PERSON | 1 |
| world health organization 2020 | ORG | 1 |
| world health organization coronavirus | ORG | 1 |
| world health organization who classification of tumors of the central nervous system 20 patient | ORG | 1 |
| world health organization who coronaviridae study group | ORG | 1 |
| world stroke organization | ORG | 1 |
| wsuhan coronavirus | GPE | 1 |
| wsuhan coronavirus disease | DISEASE | 1 |
| wuhan characteristics | ORG | 1 |
| wuhan china | LOC | 1 |
| wuhan china characteristics of ischaemic | ORG | 1 |
| wuhan clinical | ORG | 1 |
| wuhan genomic | ORG | 1 |
| wuhan guillain barré | ORG | 1 |
| yamanashi | GPE | 1 |
| yan chao li | PERSON | 1 |
| zandifar | PERSON | 1 |
| zhang et al | PERSON | 1 |
| zibetti | PERSON | 1 |
| zuhorn frédéric | ORG | 1 |
| a comprehensive stroke center | ORG | 1 |
| abdominal pain | DISEASE | 1 |
| abnormal movements | DISEASE | 1 |
| abscesses | DISEASE | 1 |
| acenocoumarol | CHEMICAL | 1 |
| acetylcholine | CHEMICAL | 1 |
| acetylsalicylic acid | CHEMICAL | 1 |
| acidalcohol | CHEMICAL | 1 |
| wolf rüdiger schäbitz | PERSON | 1 |
| wilske et al 25 | PERSON | 1 |
| willis md | PERSON | 1 |
| viral encephalitis | DISEASE | 1 |
| valerio gagliardo | PERSON | 1 |
| varga | PERSON | 1 |
| varicella zoster | DISEASE | 1 |
| vassilaki | CHEMICAL | 1 |
| vasuki onteddu | ORG | 1 |
| vaula | ORG | 1 |
| vaula giovanna zibetti maurizio lopiano leonardo | PERSON | 1 |
| ventilator | PERSON | 1 |
| ventura | GPE | 1 |
| venturelli | CHEMICAL | 1 |
| vinacci | CHEMICAL | 1 |
| vincenzo battaglia | PERSON | 1 |
| viral antibodies | TAXON | 1 |
| viral infection | DISEASE | 1 |
| whitehouse | PERSON | 1 |
| virginio camera | PERSON | 1 |
| virus infections | DISEASE | 1 |